Node1	Node2	P_value	Adj_p_value	Fisher_p_value	zt_pois_cdf	Raw_co_occurrence	Expansion
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	C3	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	RACGAP1	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	adp ribose transferases/pharmacology	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	amides/pharmacology	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	botulinum toxins/pharmacology	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	caspase 3/metabolism	0.000475505	0.000885677	0.063694268	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	myocytes cardiac/drug effects	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	phosphatidylserines/metabolism	7.80E-05	0.000163042	0.050955414	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	phospholipid transfer proteins/metabolism	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	pyridines/pharmacology	0	0	0.006369427	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	rho gtp-binding proteins/antagonists & inhibitors	0	0	0.012738854	0.704306703	1	4
1-(5-isoquinolinesulfonyl)-2-methylpiperazine/analogs & derivatives	rho-associated kinases/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenyl-1236-tetrahydropyridine	OPA1	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	PTPN2	5.52E-05	0.000222049	0.033333333	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	cell differentiation/drug effects	5.10E-09	4.74E-08	0.016666667	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	dopaminergic neurons/drug effects	5.10E-09	4.74E-08	0.016666667	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	gtp phosphohydrolases/genetics	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	induced pluripotent stem cells/drug effects	0.000823042	0.002478218	0.05	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	lysosomes/drug effects	5.10E-09	4.74E-08	0.016666667	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	membrane potential mitochondrial/drug effects	0.00360892	0.008966601	0.064516129	0.682254817	1	1
1-methyl-4-phenyl-1236-tetrahydropyridine	mutation/genetics	0.003369995	0.00669148	0.108910891	0.675762622	1	3
1-methyl-4-phenyl-1236-tetrahydropyridine	necrosis	5.10E-09	4.74E-08	0.016666667	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	neural stem cells/drug effects	0.00118177	0.003391057	0.05	0.684648414	1	0
1-methyl-4-phenyl-1236-tetrahydropyridine	neuroprotective agents/pharmacology	0.002834813	0.006457452	0.071428571	0.6737233	1	2
1-methyl-4-phenyl-1236-tetrahydropyridine	oxidative stress/drug effects	0.003266123	0.007334505	0.071428571	0.6737233	1	2
1-methyl-4-phenyl-1236-tetrahydropyridine	parkinson disease/pathology	0.000122323	0.000331086	0.069306931	0.675762622	1	3
1-methyl-4-phenyl-1236-tetrahydropyridine	small molecule libraries/pharmacology	5.10E-09	4.74E-08	0.016666667	0.684648414	1	0
1-methyl-4-phenylpyridinium/metabolism	SLC6A3	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	antioxidants/pharmacology	1.58E-05	3.59E-05	0.038216561	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	caspase inhibitors/pharmacology	8.02E-07	2.13E-06	0.038216561	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	cytoprotection	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	dopamine plasma membrane transport proteins/metabolism	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	dopaminergic neurons/drug effects	9.99E-16	4.87E-15	0.012738854	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	dose-response relationship drug	0.00386251	0.006286294	0.095541401	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	energy metabolism/drug effects	0	0	0.012738854	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	genes reporter	6.22E-15	2.92E-14	0.012738854	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	iron chelating agents/pharmacology	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	oxidative stress/drug effects	0.000124192	0.000249787	0.057324841	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	protein kinase inhibitors/pharmacology	2.58E-13	1.11E-12	0.012738854	0.704306703	1	4
1-methyl-4-phenylpyridinium/metabolism	uncoupling agents/pharmacology	9.99E-16	4.87E-15	0.012738854	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	CA2	5.45E-12	2.14E-11	0.01910828	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	calcium/metabolism	5.70E-05	0.000120985	0.057324841	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	calpain/drug effects	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	caspases/drug effects	3.37E-11	1.28E-10	0.025477707	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	chromatin/drug effects	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	exocytosis/drug effects	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	intracellular membranes/drug effects	1.14E-12	4.64E-12	0.01910828	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	neurons/cytology	4.82E-09	1.57E-08	0.038216561	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	nitric oxide/biosynthesis	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	receptors n-methyl-d-aspartate/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	rotenone/pharmacology	1.11E-16	5.69E-16	0.012738854	0.704306703	1	4
1-methyl-4-phenylpyridinium/toxicity	uncoupling agents/pharmacology	1.11E-16	5.69E-16	0.012738854	0.704306703	1	4
ABCB1	ABCC1	2.71E-14	2.32E-13	0.00019802	0.360232201	2	3
ABCB1	AKT1	0.002789893	0.004653491	0.008574228	0.395836357	2	4
ABCB1	HDAC1	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	PI3	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	PRAM1	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	PTEN	0.004618023	0.007441396	0.009799118	0.395836357	2	4
ABCB1	anti-inflammatory agents/pharmacology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	antioxidants/pharmacology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	cachexia/etiology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	cell death	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	cell survival	0.000202629	0.000507497	0.039405941	0.675762622	1	3
ABCB1	cytokines/metabolism	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	inflammation/drug therapy	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	leukocytes mononuclear/drug effects	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	micrornas/genetics	0.000679809	0.001243473	0.050465458	0.704306703	1	4
ABCB1	neoplasms/complications	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	oxidants/metabolism	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	plant extracts	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCB1	triterpenes/pharmacology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	AKT1	0.002789893	0.004653491	0.008574228	0.395836357	2	4
ABCC1	HDAC1	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	PI3	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	PRAM1	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	PTEN	0.004618023	0.007441396	0.009799118	0.395836357	2	4
ABCC1	anti-inflammatory agents/pharmacology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	antioxidants/pharmacology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	cachexia/etiology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	cell death	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	cell survival	0.000202629	0.000507497	0.039405941	0.675762622	1	3
ABCC1	cytokines/metabolism	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	inflammation/drug therapy	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	leukocytes mononuclear/drug effects	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	micrornas/genetics	0.000679809	0.001243473	0.050465458	0.704306703	1	4
ABCC1	neoplasms/complications	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	oxidants/metabolism	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	plant extracts	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ABCC1	triterpenes/pharmacology	2.64E-06	9.70E-06	0.01980198	0.675762622	1	3
ACAD9	NRF1	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	PPARGC1A	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	TFAM	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	TNF	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
ACAD9	acyl-coa dehydrogenases/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	dopaminergic neurons/ultrastructure	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	electron transport complex i/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	frontal lobe/pathology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	gene expression regulation/drug effects	1.59E-05	7.14E-05	0.033333333	0.684648414	1	0
ACAD9	micrornas/genetics	7.54E-06	3.71E-05	0.033333333	0.684648414	1	0
ACAD9	mitochondrial proteins/genetics	0.000440857	0.001422781	0.05	0.684648414	1	0
ACAD9	mitochondrial turnover/physiology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	neural stem cells	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	nuclear respiratory factor 1/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	parkinson disease/pathology	0.000192697	0.000505493	0.069306931	0.675762622	1	3
ACAD9	rotenone/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
ACAD9	tumor necrosis factor-alpha/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
AFAP1-AS1	AKT1	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AFAP1-AS1	PARP1	5.13E-06	1.81E-05	0.03960396	0.675762622	1	3
AFAP1-AS1	adenosine triphosphate/biosynthesis	0	0	0.00990099	0.675762622	1	3
AFAP1-AS1	alpha-chlorohydrin/toxicity	0	0	0.00990099	0.675762622	1	3
AFAP1-AS1	caspases/drug effects	9.77E-13	7.42E-12	0.02970297	0.675762622	1	3
AFAP1-AS1	cell survival/drug effects	0.000917682	0.002068248	0.089108911	0.675762622	1	3
AFAP1-AS1	chemosterilants/toxicity	0	0	0.00990099	0.675762622	1	3
AFAP1-AS1	membrane potential mitochondrial/drug effects	0.000665485	0.001534121	0.079207921	0.675762622	1	3
AFAP1-AS1	mitochondria/drug effects	0.004714039	0.008676106	0.148514851	0.675762622	1	3
AFAP1-AS1	reactive oxygen species/metabolism	0.002573922	0.005232841	0.108910891	0.675762622	1	3
AIFM1	ANXA5	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	ATG7	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	BECN1	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	BNIP3	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	CASP3	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
AIFM1	CRTAP	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	CUX1	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	CYCS	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	CYTIP	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	DENR	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	DNM1L	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	GAPDH	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	H2BW2	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	MAP1LC3B	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	MUTYH	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	MYOG	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	PARK7	4.12E-05	0.000168133	0.05	0.684648414	1	0
AIFM1	SLC25A4	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	SOD1	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	SQSTM1	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	TNS1	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
AIFM1	UTRN	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	VDAC1	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	acetylcysteine/pharmacology	6.25E-05	0.000186235	0.03960396	0.675762622	1	3
AIFM1	acyltransferases/antagonists & inhibitors	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	apoptosis/drug effects	0.003362639	0.008691422	0.066666667	0.684648414	1	0
AIFM1	bcl-2-associated x protein/metabolism	0.003615586	0.00591861	0.062877674	0.704306703	1	4
AIFM1	benzamides/pharmacology	6.25E-05	0.000186235	0.03960396	0.675762622	1	3
AIFM1	bortezomib	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	cdc2 protein kinase/metabolism	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	cdc25 phosphatases/metabolism	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	cell division	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	cell survival	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
AIFM1	drug interactions	6.25E-05	0.000186235	0.03960396	0.675762622	1	3
AIFM1	drug resistance neoplasm	0.004868112	0.008890199	0.078019802	0.675762622	1	3
AIFM1	g2 phase	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	hydrogen peroxide/pharmacology	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
AIFM1	membrane potential mitochondrial	8.36E-05	0.000322646	0.05	0.684648414	1	0
AIFM1	mesenchymal stem cells/metabolism	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
AIFM1	multiple myeloma/drug therapy	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	necrosis/chemically induced	6.25E-05	0.000186235	0.03960396	0.675762622	1	3
AIFM1	neuromuscular junction/genetics	0.001576797	0.00275142	0.031847134	0.704306703	1	4
AIFM1	oxidative stress	0.003619594	0.009273508	0.083333333	0.684648414	1	0
AIFM1	oxidopamine	2.40E-07	1.42E-06	0.033333333	0.684648414	1	0
AIFM1	poly(adp-ribose) polymerases/metabolism	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	proteasome inhibitors	9.94E-05	0.00027557	0.03960396	0.675762622	1	3
AIFM1	rna small interfering/metabolism	0.002221235	0.004615714	0.078019802	0.675762622	1	3
AIFM1	u937 cells	0.001505636	0.003243114	0.078019802	0.675762622	1	3
AIFM1	wharton jelly/cytology	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
AKT1	BCL2	0.002770449	0.00561249	1.35E-08	1.21E-06	11	3
AKT1	CASP8	0.003404369	0.005585293	1.16E-06	2.39E-06	11	4
AKT1	CASP9	0.002935151	0.004864582	7.43E-07	2.39E-06	11	4
AKT1	NGF	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	PIK3CA	7.88E-05	0.000227235	1.35E-06	0.004574958	6	3
AKT1	PTEN	0.000790172	0.001798351	1.93E-09	1.21E-06	11	3
AKT1	adenosine triphosphate/biosynthesis	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	alpha-chlorohydrin/toxicity	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	aspartic acid/analogs & derivatives	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	cell division/drug effects	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	cell line tumor	1.39E-06	7.58E-06	0.05	0.684648414	1	0
AKT1	chemosterilants/toxicity	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	induced pluripotent stem cells	8.24E-06	4.01E-05	0.066666667	0.684648414	1	0
AKT1	mitophagy	0.000103528	0.000392694	0.083333333	0.684648414	1	0
AKT1	nerve growth factor/pharmacology	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	neurites/physiology	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	neurons/cytology	1.53E-05	7.02E-05	0.083333333	0.684648414	1	0
AKT1	proto-oncogene proteins c-akt/genetics	0	0	0.016666667	0.684648414	1	0
AKT1	superior cervical ganglion/cytology	0.00505972	0.008096797	0.095541401	0.704306703	1	4
AKT1	ubiquitin/metabolism	0	0	0.016666667	0.684648414	1	0
ANXA5	ATG7	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	BECN1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	BNIP3	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	CASP12	0.000192697	0.000505493	0.01980198	0.675762622	1	3
ANXA5	CRTAP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	CUX1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	CYCS	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
ANXA5	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
ANXA5	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
ANXA5	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
ANXA5	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ANXA5	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
ANXA5	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
ANXA5	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
ANXA5	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATF6	HSPA5	0	0	0.006369427	0.704306703	1	4
ATF6	amino acid chloromethyl ketones/pharmacology	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
ATF6	autophagy/drug effects	0	0	0.006369427	0.704306703	1	4
ATF6	caspase 9/metabolism	1.03E-07	3.01E-07	0.031847134	0.704306703	1	4
ATF6	cell line tumor	0.00062569	0.001147958	0.089171975	0.704306703	1	4
ATF6	dose-response relationship drug	0.000952704	0.001707535	0.095541401	0.704306703	1	4
ATF6	drug interactions	0	0	0.012738854	0.704306703	1	4
ATF6	endoplasmic reticulum/drug effects	0	0	0.01910828	0.704306703	1	4
ATF6	hiv protease inhibitors/pharmacology	0	0	0.006369427	0.704306703	1	4
ATF6	ovarian neoplasms/drug therapy	0	0	0.006369427	0.704306703	1	4
ATF6	saquinavir/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
ATG7	BECN1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	BNIP3	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	CASP12	0.000192697	0.000505493	0.01980198	0.675762622	1	3
ATG7	CRTAP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	CUX1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	CYCS	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
ATG7	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
ATG7	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
ATG7	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
ATG7	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATG7	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
ATG7	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
ATG7	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
ATG7	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
ATP13A2	PARK7	1.96E-06	1.04E-05	0.05	0.684648414	1	0
ATP13A2	PRKN	0.000849282	0.00192244	0.138613861	0.675762622	1	3
ATP13A2	cell line	0.004816425	0.008798757	0.168316832	0.675762622	1	3
ATP13A2	dopaminergic neurons/metabolism	0.004641712	0.008570101	0.207920792	0.675762622	1	3
ATP13A2	genes recessive	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
ATP13A2	genetic predisposition to disease	1.11E-05	5.18E-05	0.05	0.684648414	1	0
ATP13A2	mutation	0.004413946	0.007122054	0.210191083	0.704306703	1	4
ATP13A2	parkinson disease/diagnosis	1.75E-07	1.10E-06	0.033333333	0.684648414	1	0
ATP13A2	phenotype	0.000112283	0.000306115	0.108910891	0.675762622	1	3
ATP13A2	pluripotent stem cells/cytology	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
ATP13A2	tyrosine 3-monooxygenase/genetics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
ATXN1	GFI1	0	0	0.014285714	0.6737233	1	2
ATXN1	cells cultured	0.000171686	0.000454756	0.138613861	0.675762622	1	3
ATXN1	dna-binding proteins/genetics	2.17E-12	2.66E-11	0.042857143	0.6737233	1	2
ATXN1	drosophila proteins/genetics	0.000221782	0.000669855	0.114285714	0.6737233	1	2
ATXN1	nerve degeneration/genetics	0.000106755	0.000347613	0.1	0.6737233	1	2
ATXN1	nervous system malformations/genetics	0	0	0.014285714	0.6737233	1	2
ATXN1	purkinje cells/metabolism	0	0	0.014285714	0.6737233	1	2
ATXN1	spinocerebellar ataxias/genetics	0	0	0.014285714	0.6737233	1	2
ATXN1	transcription factors/genetics	2.74E-07	1.38E-06	0.071428571	0.6737233	1	2
BCL2	CASP3	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
BCL2	CASP8	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BCL2	CASP9	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BCL2	PIK3CA	0.000444157	0.000834275	6.41E-05	0.022707082	5	4
BCL2	PTEN	0.001845864	0.004497814	0.08447205	0.6737233	1	2
BCL2	adenosine triphosphate/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
BCL2	brain/metabolism	0.003926407	0.008718421	0.111801242	0.6737233	1	2
BCL2	caspases/metabolism	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BCL2	dopamine/metabolism	0.000334617	0.001078969	0.064516129	0.682254817	1	1
BCL2	gene expression regulation/drug effects	9.06E-05	0.000338016	0.048387097	0.682254817	1	1
BCL2	muscle skeletal/pathology	1.12E-07	5.95E-07	0.028571429	0.6737233	1	2
BCL2	neostriatum/drug effects	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BCL2	neurons/drug effects	0.000496443	0.001531326	0.064516129	0.682254817	1	1
BCL2	rna messenger/genetics	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BCL2	rotenone	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BCL2	ubiquitin-protein ligases	0.000115304	0.000373404	0.056728778	0.6737233	1	2
BCL2	ursodeoxycholic acid/pharmacology	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
BECN1	BNIP3	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	CASP12	0.000192697	0.000505493	0.01980198	0.675762622	1	3
BECN1	CRTAP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	CUX1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	CYCS	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
BECN1	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
BECN1	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
BECN1	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
BECN1	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BECN1	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
BECN1	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
BECN1	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
BECN1	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	CASP12	0.000192697	0.000505493	0.01980198	0.675762622	1	3
BNIP3	CRTAP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	CUX1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	CYCS	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
BNIP3	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
BNIP3	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
BNIP3	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
BNIP3	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
BNIP3	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
BNIP3	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
BNIP3	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
BNIP3	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
C3	RACGAP1	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
C3	adp ribose transferases/pharmacology	0	0	0.006369427	0.704306703	1	4
C3	amides/pharmacology	0	0	0.006369427	0.704306703	1	4
C3	botulinum toxins/pharmacology	0	0	0.006369427	0.704306703	1	4
C3	caspase 3/metabolism	0.000475505	0.000885677	0.063694268	0.704306703	1	4
C3	myocytes cardiac/drug effects	0	0	0.006369427	0.704306703	1	4
C3	phosphatidylserines/metabolism	7.80E-05	0.000163042	0.050955414	0.704306703	1	4
C3	phospholipid transfer proteins/metabolism	0	0	0.006369427	0.704306703	1	4
C3	pyridines/pharmacology	0	0	0.006369427	0.704306703	1	4
C3	rho gtp-binding proteins/antagonists & inhibitors	0	0	0.012738854	0.704306703	1	4
C3	rho-associated kinases/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
CA2	MFN2	1.80E-06	9.65E-06	0.033333333	0.684648414	1	0
CA2	RMDN3	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CA2	VAPB	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CA2	calcium/metabolism	0.003864335	0.007374722	0.115841584	0.675762622	1	3
CA2	calpain/drug effects	5.45E-12	2.14E-11	0.01910828	0.704306703	1	4
CA2	caspases/drug effects	0.000138459	0.000277887	0.074969575	0.704306703	1	4
CA2	cations divalent/metabolism	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CA2	chromatin/drug effects	5.45E-12	2.14E-11	0.01910828	0.704306703	1	4
CA2	cytosol/metabolism	0.002419482	0.005711132	0.08447205	0.6737233	1	2
CA2	endoplasmic reticulum/metabolism	4.56E-09	4.67E-08	0.000564972	0.371068466	2	0
CA2	exocytosis/drug effects	5.45E-12	2.14E-11	0.01910828	0.704306703	1	4
CA2	fibroblasts	0.000516484	0.001618315	0.066101695	0.684648414	1	0
CA2	gene expression regulation	3.13E-05	9.62E-05	0.058811881	0.675762622	1	3
CA2	glycogen synthase kinase 3 beta/metabolism	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CA2	gtp phosphohydrolases/biosynthesis	1.80E-06	9.65E-06	0.033333333	0.684648414	1	0
CA2	hek293 cells	0.003664646	0.008194604	0.08447205	0.6737233	1	2
CA2	homeostasis/physiology	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CA2	induced pluripotent stem cells/metabolism	0.002475515	0.005074432	0.059405941	0.360232201	2	3
CA2	intracellular membranes/drug effects	4.19E-05	9.11E-05	0.056591487	0.704306703	1	4
CA2	mitochondrial proteins/metabolism	0.004772384	0.008752048	0.134455446	0.675762622	1	3
CA2	mitophagy/genetics	0.001040914	0.002321973	0.097029703	0.675762622	1	3
CA2	mutation	0.002475515	0.005074432	0.045742574	0.360232201	2	3
CA2	neurons/cytology	0.00080674	0.001462985	0.111006622	0.704306703	1	4
CA2	nitric oxide/biosynthesis	5.45E-12	2.14E-11	0.01910828	0.704306703	1	4
CA2	protein tyrosine phosphatases/metabolism	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CA2	receptors n-methyl-d-aspartate/antagonists & inhibitors	5.45E-12	2.14E-11	0.01910828	0.704306703	1	4
CA2	rotenone/pharmacology	1.84E-06	4.77E-06	0.037971583	0.704306703	1	4
CA2	uncoupling agents/pharmacology	1.84E-06	4.77E-06	0.037971583	0.704306703	1	4
CA2	vesicular transport proteins/metabolism	0.000133262	0.000485659	0.033333333	0.684648414	1	0
CASP12	CRTAP	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	CUX1	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	CYCS	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	CYTIP	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	DENR	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	DNM1L	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	GAPDH	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	H2BW2	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	MAP1LC3B	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	MUTYH	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	MYOG	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	PPARGC1A	0.002624163	0.005322074	0.039405941	0.675762622	1	3
CASP12	RACGAP1	0.001195998	0.002628638	0.039405941	0.675762622	1	3
CASP12	SLC25A4	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	SOD1	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	SOD2	0.002890106	0.005837531	0.039405941	0.675762622	1	3
CASP12	SQSTM1	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	UTRN	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	VDAC1	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP12	caspases/biosynthesis	4.83E-09	2.61E-08	0.01980198	0.675762622	1	3
CASP12	cytochromes c/metabolism	4.83E-09	2.61E-08	0.01980198	0.675762622	1	3
CASP12	drugs chinese herbal/toxicity	4.83E-09	2.61E-08	0.01980198	0.675762622	1	3
CASP12	hepatocytes/drug effects	4.83E-09	2.61E-08	0.01980198	0.675762622	1	3
CASP12	mitochondria liver/drug effects	4.83E-09	2.61E-08	0.01980198	0.675762622	1	3
CASP12	mitogen-activated protein kinases/physiology	4.83E-09	2.61E-08	0.01980198	0.675762622	1	3
CASP12	neuromuscular junction/genetics	0.000192697	0.000505493	0.01980198	0.675762622	1	3
CASP2	antineoplastic agents phytogenic/pharmacology	4.22E-08	2.01E-07	0.01980198	0.675762622	1	3
CASP2	bcl-2-associated x protein/metabolism	8.02E-07	2.13E-06	0.025396048	0.704306703	1	4
CASP2	benzothiazoles/pharmacology	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP2	caspase 2/metabolism	3.83E-08	1.14E-07	0.025396048	0.704306703	1	4
CASP2	caspase 9/metabolism	0.001791498	0.00309349	0.062877674	0.704306703	1	4
CASP2	caspases/metabolism	1.52E-05	4.87E-05	0.03960396	0.675762622	1	3
CASP2	cell cycle proteins/antagonists & inhibitors	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP2	dna damage	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP2	dose-response relationship drug	0.000240424	0.000593409	0.069306931	0.675762622	1	3
CASP2	etoposide/pharmacology	0.000343329	0.000652206	0.050465458	0.704306703	1	4
CASP2	hl-60 cells	6.17E-11	4.16E-10	0.02970297	0.675762622	1	3
CASP2	intracellular membranes/drug effects	0	0	0.00990099	0.675762622	1	3
CASP2	leukemia promyelocytic acute	0	0	0.00990099	0.675762622	1	3
CASP2	melanoma/pathology	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP2	necrosis/drug therapy	0	0	0.00990099	0.675762622	1	3
CASP2	nf-kappa b/metabolism	4.92E-14	4.10E-13	0.01980198	0.675762622	1	3
CASP2	protein kinase inhibitors/pharmacology	8.02E-07	2.13E-06	0.025396048	0.704306703	1	4
CASP2	toluene/analogs & derivatives	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP2	tumor cells cultured/drug effects	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP2	tumor suppressor protein p53/metabolism	5.22E-11	1.97E-10	0.012738854	0.704306703	1	4
CASP3	CASP8	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	CASP9	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	PARK7	4.12E-05	0.000168133	0.05	0.684648414	1	0
CASP3	TNS1	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
CASP3	apoptosis/drug effects	0.003362639	0.008691422	0.066666667	0.684648414	1	0
CASP3	caspases/metabolism	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	cell survival	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
CASP3	hydrogen peroxide/pharmacology	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
CASP3	membrane potential mitochondrial	8.36E-05	0.000322646	0.05	0.684648414	1	0
CASP3	mesenchymal stem cells/metabolism	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
CASP3	neostriatum/drug effects	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	oxidative stress	0.003619594	0.009273508	0.083333333	0.684648414	1	0
CASP3	oxidopamine	2.40E-07	1.42E-06	0.033333333	0.684648414	1	0
CASP3	rna messenger/genetics	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	rotenone	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	ursodeoxycholic acid/pharmacology	2.70E-06	1.43E-05	0.032258065	0.682254817	1	1
CASP3	wharton jelly/cytology	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
CASP8	CASP9	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP8	MAPK8	0.004014693	0.006518911	0.033153683	0.395836357	2	4
CASP8	PIK3CA	0.000830086	0.001500973	2.52E-05	0.006469601	6	4
CASP8	PTEN	0.002333697	0.003947878	1.96E-07	3.79E-07	12	4
CASP8	adenosine triphosphate/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
CASP8	apoptosis	0.003401695	0.005581796	0.002522712	0.022707082	5	4
CASP8	apoptosis/drug effects	0.003096671	0.007016955	0.071428571	0.6737233	1	2
CASP8	caspases/metabolism	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP8	dopamine/metabolism	0.000334617	0.001078969	0.064516129	0.682254817	1	1
CASP8	endothelial cells/drug effects	0.006053996	0.009552249	0.033153683	0.395836357	2	4
CASP8	gene expression regulation/drug effects	9.06E-05	0.000338016	0.048387097	0.682254817	1	1
CASP8	neostriatum/drug effects	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP8	neurons/drug effects	0.000496443	0.001531326	0.064516129	0.682254817	1	1
CASP8	nf-kappa b/metabolism	0.004180489	0.006770566	0.005775158	0.18130336	3	4
CASP8	rna messenger/genetics	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP8	rotenone	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP8	ursodeoxycholic acid/pharmacology	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP9	MAPK8	0.003710807	0.006066846	0.030867222	0.395836357	2	4
CASP9	PIK3CA	0.000724103	0.001320777	2.00E-05	0.006469601	6	4
CASP9	PTEN	0.001987123	0.003413853	1.18E-07	3.79E-07	12	4
CASP9	adenosine triphosphate/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
CASP9	apoptosis	0.003053305	0.005051984	0.002114158	0.022707082	5	4
CASP9	apoptosis/drug effects	0.003096671	0.007016955	0.071428571	0.6737233	1	2
CASP9	caspases/metabolism	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP9	dopamine/metabolism	0.000334617	0.001078969	0.064516129	0.682254817	1	1
CASP9	endothelial cells/drug effects	0.005625513	0.008947153	0.030867222	0.395836357	2	4
CASP9	gene expression regulation/drug effects	9.06E-05	0.000338016	0.048387097	0.682254817	1	1
CASP9	neostriatum/drug effects	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP9	neurons/drug effects	0.000496443	0.001531326	0.064516129	0.682254817	1	1
CASP9	rna messenger/genetics	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP9	rotenone	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CASP9	ursodeoxycholic acid/pharmacology	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
CD4	CD83	0	0	0.006369427	0.704306703	1	4
CD4	CD86	0	0	0.006369427	0.704306703	1	4
CD4	CIITA	0	0	0.006369427	0.704306703	1	4
CD4	IFNG	0	0	0.006369427	0.704306703	1	4
CD4	antigens cd/metabolism	0	0	0.006369427	0.704306703	1	4
CD4	b7-2 antigen/metabolism	0	0	0.006369427	0.704306703	1	4
CD4	cell differentiation/genetics	0.001280871	0.002261658	0.076433121	0.704306703	1	4
CD4	cell self renewal	8.27E-14	3.68E-13	0.012738854	0.704306703	1	4
CD4	dendritic cells/metabolism	0	0	0.006369427	0.704306703	1	4
CD4	deoxyribonucleases/classification	0	0	0.006369427	0.704306703	1	4
CD4	embryoid bodies/metabolism	0	0	0.006369427	0.704306703	1	4
CD4	fibroblasts/metabolism	2.80E-10	9.95E-10	0.01910828	0.704306703	1	4
CD4	histocompatibility antigens class ii/genetics	0	0	0.006369427	0.704306703	1	4
CD4	human embryonic stem cells/metabolism	0.000526733	0.000975187	0.063694268	0.704306703	1	4
CD4	immunoglobulins/metabolism	0	0	0.006369427	0.704306703	1	4
CD4	interferon-gamma/metabolism	3.90E-11	1.48E-10	0.012738854	0.704306703	1	4
CD4	karyotype	0	0	0.006369427	0.704306703	1	4
CD4	nuclear proteins/genetics	0	0	0.006369427	0.704306703	1	4
CD4	teratoma	0	0	0.006369427	0.704306703	1	4
CD4	trans-activators/genetics	0	0	0.006369427	0.704306703	1	4
CD4	tumor cells cultured	0.000123433	0.000248409	0.038216561	0.704306703	1	4
CD44	PRKN	0.000849282	0.00192244	0.138613861	0.675762622	1	3
CD44	apoptosis	9.83E-09	8.95E-08	0.033333333	0.684648414	1	0
CD44	cell differentiation/physiology	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
CD44	cell line	0.004816425	0.008798757	0.168316832	0.675762622	1	3
CD44	dopaminergic neurons/cytology	0.001714637	0.004737263	0.1	0.684648414	1	0
CD44	hyaluronan receptors/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
CD44	induced pluripotent stem cells/cytology	0.000454362	0.001070294	0.138613861	0.675762622	1	3
CD44	mitophagy/physiology	1.34E-10	1.76E-09	0.033333333	0.684648414	1	0
CD44	neural stem cells/cytology	4.98E-06	2.54E-05	0.05	0.684648414	1	0
CD44	parkinson disease/etiology	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
CD44	reactive oxygen species/metabolism	0.000465113	0.001481189	0.083333333	0.684648414	1	0
CD44	ubiquitin-protein ligases/metabolism	0.000165081	0.000438006	0.108910891	0.675762622	1	3
CD83	CD86	0	0	0.006369427	0.704306703	1	4
CD83	CIITA	0	0	0.006369427	0.704306703	1	4
CD83	IFNG	0	0	0.006369427	0.704306703	1	4
CD83	antigens cd/metabolism	0	0	0.006369427	0.704306703	1	4
CD83	b7-2 antigen/metabolism	0	0	0.006369427	0.704306703	1	4
CD83	cell differentiation/genetics	0.001280871	0.002261658	0.076433121	0.704306703	1	4
CD83	cell self renewal	8.27E-14	3.68E-13	0.012738854	0.704306703	1	4
CD83	dendritic cells/metabolism	0	0	0.006369427	0.704306703	1	4
CD83	deoxyribonucleases/classification	0	0	0.006369427	0.704306703	1	4
CD83	embryoid bodies/metabolism	0	0	0.006369427	0.704306703	1	4
CD83	fibroblasts/metabolism	2.80E-10	9.95E-10	0.01910828	0.704306703	1	4
CD83	histocompatibility antigens class ii/genetics	0	0	0.006369427	0.704306703	1	4
CD83	human embryonic stem cells/metabolism	0.000526733	0.000975187	0.063694268	0.704306703	1	4
CD83	immunoglobulins/metabolism	0	0	0.006369427	0.704306703	1	4
CD83	interferon-gamma/metabolism	3.90E-11	1.48E-10	0.012738854	0.704306703	1	4
CD83	karyotype	0	0	0.006369427	0.704306703	1	4
CD83	nuclear proteins/genetics	0	0	0.006369427	0.704306703	1	4
CD83	teratoma	0	0	0.006369427	0.704306703	1	4
CD83	trans-activators/genetics	0	0	0.006369427	0.704306703	1	4
CD83	tumor cells cultured	0.000123433	0.000248409	0.038216561	0.704306703	1	4
CD86	CIITA	0	0	0.006369427	0.704306703	1	4
CD86	IFNG	0	0	0.006369427	0.704306703	1	4
CD86	antigens cd/metabolism	0	0	0.006369427	0.704306703	1	4
CD86	b7-2 antigen/metabolism	0	0	0.006369427	0.704306703	1	4
CD86	cell differentiation/genetics	0.001280871	0.002261658	0.076433121	0.704306703	1	4
CD86	cell self renewal	8.27E-14	3.68E-13	0.012738854	0.704306703	1	4
CD86	dendritic cells/metabolism	0	0	0.006369427	0.704306703	1	4
CD86	deoxyribonucleases/classification	0	0	0.006369427	0.704306703	1	4
CD86	embryoid bodies/metabolism	0	0	0.006369427	0.704306703	1	4
CD86	fibroblasts/metabolism	2.80E-10	9.95E-10	0.01910828	0.704306703	1	4
CD86	histocompatibility antigens class ii/genetics	0	0	0.006369427	0.704306703	1	4
CD86	human embryonic stem cells/metabolism	0.000526733	0.000975187	0.063694268	0.704306703	1	4
CD86	immunoglobulins/metabolism	0	0	0.006369427	0.704306703	1	4
CD86	interferon-gamma/metabolism	3.90E-11	1.48E-10	0.012738854	0.704306703	1	4
CD86	karyotype	0	0	0.006369427	0.704306703	1	4
CD86	nuclear proteins/genetics	0	0	0.006369427	0.704306703	1	4
CD86	teratoma	0	0	0.006369427	0.704306703	1	4
CD86	trans-activators/genetics	0	0	0.006369427	0.704306703	1	4
CD86	tumor cells cultured	0.000123433	0.000248409	0.038216561	0.704306703	1	4
CFLAR	NFKB1	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
CFLAR	PIK3CA	0.001076908	0.002392471	0.059405941	0.675762622	1	3
CFLAR	apoptosis	0.000495306	0.001156987	0.069306931	0.675762622	1	3
CFLAR	cytochrome c group/metabolism	4.54E-08	2.14E-07	0.02970297	0.675762622	1	3
CFLAR	dose-response relationship drug	0.001186993	0.002609374	0.069306931	0.675762622	1	3
CFLAR	etoposide/pharmacology	0	0	0.00990099	0.675762622	1	3
CFLAR	fas receptor/metabolism	0	0	0.00990099	0.675762622	1	3
CFLAR	hela cells	0	0	0.00990099	0.675762622	1	3
CFLAR	jurkat cells	0	0	0.00990099	0.675762622	1	3
CFLAR	mitomycin/pharmacology	0	0	0.00990099	0.675762622	1	3
CFLAR	nucleic acid synthesis inhibitors/pharmacology	0	0	0.00990099	0.675762622	1	3
CFLAR	staurosporine/pharmacology	9.96E-10	5.61E-09	0.01980198	0.675762622	1	3
CHCHD10	CHCHD2	8.49E-14	1.73E-12	0.001694915	0.371068466	2	0
CHCHD10	TARDBP	3.59E-05	0.0001285	0.08447205	0.6737233	1	2
CHCHD10	amyotrophic lateral sclerosis/genetics	4.03E-10	4.86E-09	0.033333333	0.684648414	1	0
CHCHD10	cell death/genetics	3.67E-09	2.25E-08	0.042857143	0.6737233	1	2
CHCHD10	cell differentiation	0.002234886	0.004643194	0.195655566	0.675762622	1	3
CHCHD10	dna-binding proteins	2.20E-09	2.30E-08	0.033333333	0.684648414	1	0
CHCHD10	dna-binding proteins/metabolism	4.03E-10	4.86E-09	0.033333333	0.684648414	1	0
CHCHD10	human embryonic stem cells/metabolism	7.05E-06	3.54E-05	0.066101695	0.684648414	1	0
CHCHD10	mitochondria/metabolism	0.003333106	0.005477415	0.125073098	0.395836357	2	4
CHCHD10	mitochondria/pathology	6.96E-06	2.81E-05	0.08447205	0.6737233	1	2
CHCHD10	mitochondrial diseases/genetics	2.20E-09	2.30E-08	0.033333333	0.684648414	1	0
CHCHD10	mitochondrial membranes/metabolism	7.05E-06	3.54E-05	0.066101695	0.684648414	1	0
CHCHD10	mitochondrial proteins/genetics	0.00202679	0.00556211	0.098305085	0.684648414	1	0
CHCHD10	mitochondrial proteins/metabolism	0.000380266	0.00110568	0.024808184	0.357776018	2	2
CHCHD10	motor neurons/metabolism	4.03E-10	4.86E-09	0.033333333	0.684648414	1	0
CHCHD10	nerve degeneration/genetics	0.002549034	0.005193871	0.195655566	0.675762622	1	3
CHCHD10	neuromuscular junction/metabolism	3.59E-05	0.0001285	0.08447205	0.6737233	1	2
CHCHD10	oligopeptides/pharmacology	2.20E-09	2.30E-08	0.033333333	0.684648414	1	0
CHCHD10	parkinson disease/genetics	0.000867805	0.00156266	0.099706026	0.395836357	2	4
CHCHD10	synapses/metabolism	1.82E-05	8.15E-05	0.066101695	0.684648414	1	0
CHCHD10	transcription factors/genetics	2.25E-06	1.20E-05	0.066101695	0.684648414	1	0
CHCHD10	transcription factors/metabolism	4.03E-10	4.86E-09	0.033333333	0.684648414	1	0
CHCHD2	amyotrophic lateral sclerosis/genetics	4.72E-08	3.14E-07	0.05	0.684648414	1	0
CHCHD2	cell differentiation	0.000174755	0.000621894	0.033547633	0.371068466	2	0
CHCHD2	dna-binding proteins	1.75E-07	1.10E-06	0.05	0.684648414	1	0
CHCHD2	dna-binding proteins/genetics	6.30E-12	9.61E-11	0.05	0.684648414	1	0
CHCHD2	dna-binding proteins/metabolism	4.72E-08	3.14E-07	0.05	0.684648414	1	0
CHCHD2	human embryonic stem cells	6.30E-12	9.61E-11	0.05	0.684648414	1	0
CHCHD2	human embryonic stem cells/metabolism	9.07E-05	0.000347002	0.098305085	0.684648414	1	0
CHCHD2	induced pluripotent stem cells/metabolism	0.00133459	0.002903379	0.150615062	0.360232201	2	3
CHCHD2	mitochondria/metabolism	0.001848037	0.003188515	0.125073098	0.395836357	2	4
CHCHD2	mitochondrial diseases/genetics	1.75E-07	1.10E-06	0.05	0.684648414	1	0
CHCHD2	mitochondrial membranes/metabolism	9.07E-05	0.000347002	0.098305085	0.684648414	1	0
CHCHD2	mitochondrial proteins/genetics	0.000878146	0.001984479	0.142634263	0.675762622	1	3
CHCHD2	mitochondrial proteins/metabolism	0.002971441	0.005971928	0.195655566	0.675762622	1	3
CHCHD2	motor neurons/metabolism	4.72E-08	3.14E-07	0.05	0.684648414	1	0
CHCHD2	mutation/genetics	0.00092228	0.002760764	0.044184687	0.371068466	2	0
CHCHD2	oligopeptides/pharmacology	1.75E-07	1.10E-06	0.05	0.684648414	1	0
CHCHD2	parkinson disease/genetics	7.65E-06	2.59E-05	0.019657966	0.155527348	3	3
CHCHD2	synapses/metabolism	0.00018949	0.000659424	0.098305085	0.684648414	1	0
CHCHD2	transcription factors/genetics	2.22E-16	5.19E-15	0.001694915	0.371068466	2	0
CHCHD2	transcription factors/metabolism	4.72E-08	3.14E-07	0.05	0.684648414	1	0
CIITA	IFNG	0	0	0.006369427	0.704306703	1	4
CIITA	antigens cd/metabolism	0	0	0.006369427	0.704306703	1	4
CIITA	b7-2 antigen/metabolism	0	0	0.006369427	0.704306703	1	4
CIITA	cell differentiation/genetics	0.001280871	0.002261658	0.076433121	0.704306703	1	4
CIITA	cell self renewal	8.27E-14	3.68E-13	0.012738854	0.704306703	1	4
CIITA	dendritic cells/metabolism	0	0	0.006369427	0.704306703	1	4
CIITA	deoxyribonucleases/classification	0	0	0.006369427	0.704306703	1	4
CIITA	embryoid bodies/metabolism	0	0	0.006369427	0.704306703	1	4
CIITA	fibroblasts/metabolism	2.80E-10	9.95E-10	0.01910828	0.704306703	1	4
CIITA	histocompatibility antigens class ii/genetics	0	0	0.006369427	0.704306703	1	4
CIITA	human embryonic stem cells/metabolism	0.000526733	0.000975187	0.063694268	0.704306703	1	4
CIITA	immunoglobulins/metabolism	0	0	0.006369427	0.704306703	1	4
CIITA	interferon-gamma/metabolism	3.90E-11	1.48E-10	0.012738854	0.704306703	1	4
CIITA	karyotype	0	0	0.006369427	0.704306703	1	4
CIITA	nuclear proteins/genetics	0	0	0.006369427	0.704306703	1	4
CIITA	teratoma	0	0	0.006369427	0.704306703	1	4
CIITA	trans-activators/genetics	0	0	0.006369427	0.704306703	1	4
CIITA	tumor cells cultured	0.000123433	0.000248409	0.038216561	0.704306703	1	4
COMP	calcium/metabolism	0.000312711	0.000596859	0.057324841	0.704306703	1	4
COMP	cell extracts/pharmacology	4.07E-12	1.60E-11	0.012738854	0.704306703	1	4
COMP	cell membrane permeability/drug effects	0	0	0.006369427	0.704306703	1	4
COMP	cell membrane/drug effects	6.91E-09	2.21E-08	0.01910828	0.704306703	1	4
COMP	cells cultured/cytology	0	0	0.006369427	0.704306703	1	4
COMP	chick embryo	8.33E-15	3.89E-14	0.012738854	0.704306703	1	4
COMP	cytochrome c group/metabolism	9.62E-05	0.000196826	0.044585987	0.704306703	1	4
COMP	cytosol/metabolism	5.70E-07	1.54E-06	0.031847134	0.704306703	1	4
COMP	dna fragmentation/drug effects	0.000102934	0.00020998	0.044585987	0.704306703	1	4
COMP	ganglia parasympathetic/drug effects	0	0	0.006369427	0.704306703	1	4
COMP	nerve growth factors/metabolism	0	0	0.006369427	0.704306703	1	4
COMP	neurons/drug effects	0.000160756	0.000321114	0.050955414	0.704306703	1	4
COMP	neuroprotective agents/pharmacology	0.000133572	0.000268334	0.050955414	0.704306703	1	4
COMP	trypan blue	0	0	0.006369427	0.704306703	1	4
COMP	vacuoles/drug effects	0	0	0.006369427	0.704306703	1	4
CRTAP	CUX1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	CYCS	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
CRTAP	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
CRTAP	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
CRTAP	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
CRTAP	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CRTAP	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
CRTAP	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
CRTAP	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
CRTAP	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	CYCS	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
CUX1	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
CUX1	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
CUX1	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
CUX1	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CUX1	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
CUX1	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
CUX1	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
CUX1	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	CYTIP	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
CYCS	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
CYCS	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
CYCS	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
CYCS	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYCS	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
CYCS	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
CYCS	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
CYCS	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYP3A4	alleles	9.66E-14	7.80E-13	0.02970297	0.675762622	1	3
CYP3A4	amyotrophic lateral sclerosis/genetics	1.70E-06	6.78E-06	0.04950495	0.675762622	1	3
CYP3A4	apoptosis/physiology	7.00E-12	4.86E-11	0.02970297	0.675762622	1	3
CYP3A4	dna-binding proteins/genetics	7.62E-07	3.17E-06	0.04950495	0.675762622	1	3
CYP3A4	hsp70 heat-shock proteins/metabolism	0	0	0.00990099	0.675762622	1	3
CYP3A4	locomotion/genetics	0	0	0.00990099	0.675762622	1	3
CYP3A4	mutation missense/genetics	0	0	0.00990099	0.675762622	1	3
CYP3A4	neuromuscular junction/cytology	0	0	0.00990099	0.675762622	1	3
CYP3A4	neurons/metabolism	3.40E-05	0.000103588	0.099009901	0.675762622	1	3
CYP3A4	phenotype	0.000366646	0.000874255	0.108910891	0.675762622	1	3
CYP3A4	proteasome endopeptidase complex/metabolism	0	0	0.00990099	0.675762622	1	3
CYP3A4	rna interference	9.16E-10	5.24E-09	0.02970297	0.675762622	1	3
CYTIP	DENR	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
CYTIP	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
CYTIP	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
CYTIP	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
CYTIP	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
CYTIP	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
CYTIP	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
CYTIP	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
CYTIP	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	DNM1L	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
DENR	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
DENR	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
DENR	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
DENR	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DENR	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
DENR	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
DENR	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
DENR	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	GAPDH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
DNM1L	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
DNM1L	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
DNM1L	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
DNM1L	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
DNM1L	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
DNM1L	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
DNM1L	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
DNM1L	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
FOS	FOSB	0	0	0.006369427	0.704306703	1	4
FOS	FOSL2	0	0	0.006369427	0.704306703	1	4
FOS	JUN	0	0	0.006369427	0.704306703	1	4
FOS	JUND	0	0	0.006369427	0.704306703	1	4
FOS	SMARCA1	0	0	0.006369427	0.704306703	1	4
FOS	SMARCA2	0	0	0.006369427	0.704306703	1	4
FOS	SMARCA4	0	0	0.006369427	0.704306703	1	4
FOS	SOX3	0	0	0.006369427	0.704306703	1	4
FOS	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
FOS	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
FOS	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
FOS	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
FOS	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
FOS	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
FOS	heterozygote	0	0	0.012738854	0.704306703	1	4
FOS	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
FOS	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
FOS	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
FOS	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
FOSB	FOSL2	0	0	0.006369427	0.704306703	1	4
FOSB	JUN	0	0	0.006369427	0.704306703	1	4
FOSB	JUND	0	0	0.006369427	0.704306703	1	4
FOSB	SMARCA1	0	0	0.006369427	0.704306703	1	4
FOSB	SMARCA2	0	0	0.006369427	0.704306703	1	4
FOSB	SMARCA4	0	0	0.006369427	0.704306703	1	4
FOSB	SOX3	0	0	0.006369427	0.704306703	1	4
FOSB	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
FOSB	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
FOSB	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
FOSB	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
FOSB	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
FOSB	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
FOSB	heterozygote	0	0	0.012738854	0.704306703	1	4
FOSB	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
FOSB	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
FOSB	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
FOSB	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
FOSL2	JUN	0	0	0.006369427	0.704306703	1	4
FOSL2	JUND	0	0	0.006369427	0.704306703	1	4
FOSL2	SMARCA1	0	0	0.006369427	0.704306703	1	4
FOSL2	SMARCA2	0	0	0.006369427	0.704306703	1	4
FOSL2	SMARCA4	0	0	0.006369427	0.704306703	1	4
FOSL2	SOX3	0	0	0.006369427	0.704306703	1	4
FOSL2	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
FOSL2	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
FOSL2	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
FOSL2	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
FOSL2	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
FOSL2	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
FOSL2	heterozygote	0	0	0.012738854	0.704306703	1	4
FOSL2	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
FOSL2	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
FOSL2	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
FOSL2	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
FUS	GSK3B	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
FUS	RMDN3	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
FUS	VAPB	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
FUS	adenosine triphosphate/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
FUS	amyotrophic lateral sclerosis/metabolism	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
FUS	calcium/metabolism	0.001432436	0.003939891	0.064516129	0.682254817	1	1
FUS	endoplasmic reticulum/metabolism	0.000183612	0.00063942	0.048387097	0.682254817	1	1
FUS	gene expression	1.20E-06	6.54E-06	0.032258065	0.682254817	1	1
FUS	glycogen synthase kinase 3 beta/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
FUS	mitochondrial proteins/metabolism	1.89E-05	5.98E-05	0.069306931	0.675762622	1	3
FUS	protein tyrosine phosphatases/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
FUS	rna-binding protein fus/genetics	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
FUS	vesicular transport proteins/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
GABPA	NFE2L2	7.21E-06	3.61E-05	0.05	0.684648414	1	0
GABPA	cell line	0.003132746	0.006264917	0.168316832	0.675762622	1	3
GABPA	cellular reprogramming/drug effects	0	0	0.016666667	0.684648414	1	0
GABPA	gene expression regulation/drug effects	2.75E-08	2.37E-07	0.033333333	0.684648414	1	0
GABPA	induced pluripotent stem cells/cytology	0.000242345	0.00059734	0.138613861	0.675762622	1	3
GABPA	leupeptins/pharmacology	0	0	0.016666667	0.684648414	1	0
GABPA	mitochondria/metabolism	0.005806647	0.009197167	0.222929936	0.704306703	1	4
GABPA	neuroprotective agents/pharmacology	0.000516484	0.001618315	0.083333333	0.684648414	1	0
GABPA	oxidative stress/drug effects	0.000621007	0.001929559	0.083333333	0.684648414	1	0
GABPA	parkinson disease/drug therapy	0.000310999	0.001043211	0.083333333	0.684648414	1	0
GABPA	phenanthrenes/pharmacology	0	0	0.016666667	0.684648414	1	0
GAPDH	H2BW2	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
GAPDH	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
GAPDH	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
GAPDH	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
GAPDH	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GAPDH	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
GAPDH	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
GAPDH	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
GAPDH	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
GATA4	cell line	7.28E-05	0.000152817	0.229299363	0.704306703	1	4
GATA4	gata4 transcription factor/genetics	0	0	0.006369427	0.704306703	1	4
GATA4	heterozygote	0	0	0.012738854	0.704306703	1	4
GATA4	human embryonic stem cells	0	0	0.025477707	0.704306703	1	4
GATA4	mutation	6.43E-06	1.52E-05	0.210191083	0.704306703	1	4
GBA	LRRK2	0.003820041	0.009720067	0.083333333	0.684648414	1	0
GBA	PRKN	0.000737149	0.001342979	0.089171975	0.704306703	1	4
GBA	PTPN2	9.07E-05	0.000347002	0.033333333	0.684648414	1	0
GBA	SNCA	0.00241481	0.004061118	0.114649682	0.704306703	1	4
GBA	alpha-synuclein/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
GBA	dopaminergic neurons/cytology	2.33E-05	7.25E-05	0.059405941	0.675762622	1	3
GBA	genome human	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
GBA	glucosylceramidase/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
GBA	induced pluripotent stem cells/cytology	0.004728585	0.008676106	0.138613861	0.675762622	1	3
GBA	leucine-rich repeat serine-threonine protein kinase-2/genetics	0.001037649	0.003061288	0.066666667	0.684648414	1	0
GBA	mitophagy	0.003546654	0.008884338	0.080645161	0.682254817	1	1
GBA	neural stem cells/cytology	0.000216362	0.000747215	0.05	0.684648414	1	0
GBA	neurogenesis	3.06E-05	0.000128984	0.033333333	0.684648414	1	0
GBA	ubiquitin-protein ligases/genetics	0.000436312	0.001030003	0.089108911	0.675762622	1	3
GCG	TNF	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
GCG	antigens cd/genetics	0	0	0.006369427	0.704306703	1	4
GCG	antineoplastic agents phytogenic/pharmacology	1.04E-05	2.42E-05	0.025477707	0.704306703	1	4
GCG	camptothecin/pharmacology	0	0	0.006369427	0.704306703	1	4
GCG	etoposide/pharmacology	4.19E-07	1.17E-06	0.025477707	0.704306703	1	4
GCG	gene expression/drug effects	1.19E-14	5.53E-14	0.012738854	0.704306703	1	4
GCG	hepatocytes/drug effects	4.89E-10	1.71E-09	0.01910828	0.704306703	1	4
GCG	nf-kappa b/metabolism	3.29E-10	1.16E-09	0.01910828	0.704306703	1	4
GCG	receptors tumor necrosis factor type i	0	0	0.006369427	0.704306703	1	4
GCG	rna messenger/analysis	0	0	0.006369427	0.704306703	1	4
GCG	specific pathogen-free organisms	0	0	0.006369427	0.704306703	1	4
GCG	topoisomerase inhibitors	0	0	0.006369427	0.704306703	1	4
GCG	tumor necrosis factor-alpha/pharmacology	2.99E-13	1.28E-12	0.012738854	0.704306703	1	4
GFI1	cells cultured	0.000171686	0.000454756	0.138613861	0.675762622	1	3
GFI1	dna-binding proteins/genetics	2.17E-12	2.66E-11	0.042857143	0.6737233	1	2
GFI1	drosophila proteins/genetics	0.000221782	0.000669855	0.114285714	0.6737233	1	2
GFI1	nerve degeneration/genetics	0.000106755	0.000347613	0.1	0.6737233	1	2
GFI1	nervous system malformations/genetics	0	0	0.014285714	0.6737233	1	2
GFI1	purkinje cells/metabolism	0	0	0.014285714	0.6737233	1	2
GFI1	spinocerebellar ataxias/genetics	0	0	0.014285714	0.6737233	1	2
GFI1	transcription factors/genetics	2.74E-07	1.38E-06	0.071428571	0.6737233	1	2
GSK3B	PARP1	0.002178884	0.003697593	0.062877674	0.704306703	1	4
GSK3B	PCNA	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	RAF1	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	RMDN3	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
GSK3B	VAPB	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
GSK3B	adenosine triphosphate/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
GSK3B	amyotrophic lateral sclerosis/metabolism	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
GSK3B	calcium/metabolism	0.001432436	0.003939891	0.064516129	0.682254817	1	1
GSK3B	caspase 8/metabolism	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	caspase 9/metabolism	0.000270458	0.000664828	0.039405941	0.675762622	1	3
GSK3B	cytochrome p-450 cyp3a/metabolism	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	cytotoxins/chemistry	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	dna fragmentation/drug effects	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	endoplasmic reticulum/metabolism	0.000183612	0.00063942	0.048387097	0.682254817	1	1
GSK3B	gene expression	1.20E-06	6.54E-06	0.032258065	0.682254817	1	1
GSK3B	glycogen synthase kinase 3 beta/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
GSK3B	hep g2 cells	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	mitochondrial proteins/metabolism	0.001369196	0.00240856	0.087457129	0.704306703	1	4
GSK3B	phosphatidylserines/metabolism	2.33E-05	7.25E-05	0.039405941	0.675762622	1	3
GSK3B	plant extracts/toxicity	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	plant roots/chemistry	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
GSK3B	protein tyrosine phosphatases/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
GSK3B	rna-binding protein fus/genetics	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
GSK3B	vesicular transport proteins/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
GSK3B	water/chemistry	3.31E-07	1.42E-06	0.01980198	0.675762622	1	3
H2BW2	MAP1LC3B	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
H2BW2	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
H2BW2	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
H2BW2	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
H2BW2	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
H2BW2	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
H2BW2	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
H2BW2	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
H2BW2	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
HDAC1	PI3	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	PRAM1	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	anti-inflammatory agents/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	antioxidants/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	cachexia/etiology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	caspases/metabolism	0.001820581	0.003843069	0.03960396	0.675762622	1	3
HDAC1	cell death	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	cell survival	4.52E-06	1.60E-05	0.01980198	0.675762622	1	3
HDAC1	cytokines/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	inflammation/drug therapy	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	leukocytes mononuclear/drug effects	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	neoplasms/complications	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	oxidants/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	oxidative stress/drug effects	0.003172487	0.006322346	0.059405941	0.675762622	1	3
HDAC1	plant extracts	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HDAC1	triterpenes/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
HNF1A	cell respiration	0	0	0.01910828	0.704306703	1	4
HNF1A	cells cultured	0.000900018	0.001616189	0.152866242	0.704306703	1	4
HNF1A	diabetes mellitus type 2/metabolism	0	0	0.006369427	0.704306703	1	4
HNF1A	gene expression regulation	0	0	0.025477707	0.704306703	1	4
HNF1A	hepatocyte nuclear factor 1-alpha/genetics	0	0	0.006369427	0.704306703	1	4
HNF1A	human embryonic stem cells/physiology	0	0	0.01910828	0.704306703	1	4
HNF1A	mutation/genetics	8.93E-06	2.09E-05	0.089171975	0.704306703	1	4
HNF1A	pancreas/pathology	0	0	0.006369427	0.704306703	1	4
HNF1A	phenotype	4.54E-06	1.10E-05	0.089171975	0.704306703	1	4
HNF1A	rna long noncoding/genetics	0	0	0.012738854	0.704306703	1	4
HSPA5	amino acid chloromethyl ketones/pharmacology	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
HSPA5	autophagy/drug effects	0	0	0.006369427	0.704306703	1	4
HSPA5	caspase 9/metabolism	1.03E-07	3.01E-07	0.031847134	0.704306703	1	4
HSPA5	cell line tumor	0.00062569	0.001147958	0.089171975	0.704306703	1	4
HSPA5	dose-response relationship drug	0.000952704	0.001707535	0.095541401	0.704306703	1	4
HSPA5	drug interactions	0	0	0.012738854	0.704306703	1	4
HSPA5	endoplasmic reticulum/drug effects	0	0	0.01910828	0.704306703	1	4
HSPA5	hiv protease inhibitors/pharmacology	0	0	0.006369427	0.704306703	1	4
HSPA5	ovarian neoplasms/drug therapy	0	0	0.006369427	0.704306703	1	4
HSPA5	saquinavir/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
IFNG	antigens cd/metabolism	0	0	0.006369427	0.704306703	1	4
IFNG	b7-2 antigen/metabolism	0	0	0.006369427	0.704306703	1	4
IFNG	cell differentiation/genetics	0.001280871	0.002261658	0.076433121	0.704306703	1	4
IFNG	cell self renewal	8.27E-14	3.68E-13	0.012738854	0.704306703	1	4
IFNG	dendritic cells/metabolism	0	0	0.006369427	0.704306703	1	4
IFNG	deoxyribonucleases/classification	0	0	0.006369427	0.704306703	1	4
IFNG	embryoid bodies/metabolism	0	0	0.006369427	0.704306703	1	4
IFNG	fibroblasts/metabolism	2.80E-10	9.95E-10	0.01910828	0.704306703	1	4
IFNG	histocompatibility antigens class ii/genetics	0	0	0.006369427	0.704306703	1	4
IFNG	human embryonic stem cells/metabolism	0.000526733	0.000975187	0.063694268	0.704306703	1	4
IFNG	immunoglobulins/metabolism	0	0	0.006369427	0.704306703	1	4
IFNG	interferon-gamma/metabolism	3.90E-11	1.48E-10	0.012738854	0.704306703	1	4
IFNG	karyotype	0	0	0.006369427	0.704306703	1	4
IFNG	nuclear proteins/genetics	0	0	0.006369427	0.704306703	1	4
IFNG	teratoma	0	0	0.006369427	0.704306703	1	4
IFNG	trans-activators/genetics	0	0	0.006369427	0.704306703	1	4
IFNG	tumor cells cultured	0.000123433	0.000248409	0.038216561	0.704306703	1	4
IL1B	TNF	2.91E-09	1.60E-08	0.03960396	0.675762622	1	3
IL1B	acetylcysteine/pharmacology	2.45E-06	6.27E-06	0.037971583	0.704306703	1	4
IL1B	antioxidants/pharmacology	0.001403896	0.002464983	0.075208231	0.704306703	1	4
IL1B	apoptosis/genetics	2.11E-15	1.86E-14	0.01980198	0.675762622	1	3
IL1B	caspase inhibitors/pharmacology	0.00024911	0.000490074	0.075208231	0.704306703	1	4
IL1B	cell line tumor	0.000283216	0.000691819	0.089108911	0.675762622	1	3
IL1B	neurons/drug effects	0.002522585	0.00423689	0.099624367	0.704306703	1	4
IL1B	rna small interfering/metabolism	0	0	0.01980198	0.675762622	1	3
JUN	JUND	0	0	0.006369427	0.704306703	1	4
JUN	SMARCA1	0	0	0.006369427	0.704306703	1	4
JUN	SMARCA2	0	0	0.006369427	0.704306703	1	4
JUN	SMARCA4	0	0	0.006369427	0.704306703	1	4
JUN	SOX3	0	0	0.006369427	0.704306703	1	4
JUN	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
JUN	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
JUN	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
JUN	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
JUN	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
JUN	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
JUN	heterozygote	0	0	0.012738854	0.704306703	1	4
JUN	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
JUN	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
JUN	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
JUN	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
JUND	SMARCA1	0	0	0.006369427	0.704306703	1	4
JUND	SMARCA2	0	0	0.006369427	0.704306703	1	4
JUND	SMARCA4	0	0	0.006369427	0.704306703	1	4
JUND	SOX3	0	0	0.006369427	0.704306703	1	4
JUND	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
JUND	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
JUND	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
JUND	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
JUND	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
JUND	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
JUND	heterozygote	0	0	0.012738854	0.704306703	1	4
JUND	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
JUND	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
JUND	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
JUND	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
KLF7	OSMR	0	0	0.006369427	0.704306703	1	4
KLF7	STAT5A	0	0	0.006369427	0.704306703	1	4
KLF7	cell line	0.006017887	0.009499708	0.229299363	0.704306703	1	4
KLF7	crispr-cas systems/genetics	0	0	0.01910828	0.704306703	1	4
KLF7	homologous recombination	0	0	0.006369427	0.704306703	1	4
KLF7	homozygote	0	0	0.012738854	0.704306703	1	4
KLF7	human embryonic stem cells/metabolism	1.83E-07	5.22E-07	0.063694268	0.704306703	1	4
KLF7	kruppel-like transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
KLF7	mutation/genetics	8.93E-06	2.09E-05	0.089171975	0.704306703	1	4
KLF7	oncostatin m receptor beta subunit/genetics	0	0	0.006369427	0.704306703	1	4
LRRK2	PTPN2	0.000637846	0.001472587	0.097029703	0.675762622	1	3
LRRK2	axons/metabolism	0.00016364	0.000435454	0.097029703	0.675762622	1	3
LRRK2	cell survival/genetics	0.001260331	0.002752823	0.142634263	0.675762622	1	3
LRRK2	dopaminergic neurons/cytology	1.29E-05	4.17E-05	0.027357535	0.360232201	2	3
LRRK2	genome human	0.003820041	0.009720067	0.083333333	0.684648414	1	0
LRRK2	glucosylceramidase/genetics	0.003820041	0.009720067	0.083333333	0.684648414	1	0
LRRK2	group iii histone deacetylases/genetics	9.38E-06	4.46E-05	0.083333333	0.684648414	1	0
LRRK2	indoles/therapeutic use	7.92E-05	0.000308876	0.083333333	0.684648414	1	0
LRRK2	induced pluripotent stem cells/cytology	0.004050782	0.006574353	0.114807148	0.395836357	2	4
LRRK2	leucine-rich repeat serine-threonine protein kinase-2/genetics	4.63E-07	2.70E-06	0.001138146	0.163189624	3	0
LRRK2	mitochondria/genetics	2.82E-05	8.74E-05	0.061662661	0.360232201	2	3
LRRK2	mitophagy	0.002188494	0.005254595	0.037835699	0.357776018	2	2
LRRK2	mutation	0.001791459	0.003800921	0.067529905	0.155527348	3	3
LRRK2	nerve degeneration/complications	0.002855211	0.007488747	0.083333333	0.684648414	1	0
LRRK2	neural stem cells/cytology	0.00016736	0.000597151	0.016364699	0.371068466	2	0
LRRK2	neurites/metabolism	0.001076908	0.002392471	0.142634263	0.675762622	1	3
LRRK2	neurogenesis	0.000272555	0.000669679	0.097029703	0.675762622	1	3
LRRK2	neuroprotection	0.002855211	0.007488747	0.083333333	0.684648414	1	0
LRRK2	oxidative stress/genetics	3.06E-05	0.000128984	0.083333333	0.684648414	1	0
LRRK2	parkinson disease/complications	3.19E-05	9.80E-05	0.097029703	0.675762622	1	3
LRRK2	parkinson disease/genetics	0.005281053	0.009560996	0.128802483	0.155527348	3	3
LRRK2	phenols/therapeutic use	7.92E-05	0.000308876	0.083333333	0.684648414	1	0
LRRK2	rho gtp-binding proteins/metabolism	0.002855211	0.007488747	0.083333333	0.684648414	1	0
LRRK2	rna interference	0.004757758	0.008726693	0.142634263	0.675762622	1	3
LRRK2	sirolimus/therapeutic use	7.92E-05	0.000308876	0.083333333	0.684648414	1	0
LRRK2	stress physiological	0.000343674	0.000822538	0.097029703	0.675762622	1	3
LRRK2	ubiquinone/therapeutic use	7.92E-05	0.000308876	0.083333333	0.684648414	1	0
MAP1B	NFE2L2	0.000516484	0.001618315	0.05	0.684648414	1	0
MAP1B	PRKCA	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	PRKCB	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	PRKCG	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	PRRT2	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	alpha-synuclein/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
MAP1B	cell differentiation/genetics	0.000276783	0.000677928	0.079207921	0.675762622	1	3
MAP1B	microtubule-associated proteins/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	neurites/metabolism	0.000177032	0.000621894	0.05	0.684648414	1	0
MAP1B	nf-e2-related factor 2/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	parkinson disease/drug therapy	0.0026219	0.006119054	0.071428571	0.6737233	1	2
MAP1B	pluripotent stem cells/metabolism	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	protein kinase c/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
MAP1B	substantia nigra/metabolism	0.000140559	0.000374859	0.069306931	0.675762622	1	3
MAP1LC3B	MUTYH	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
MAP1LC3B	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
MAP1LC3B	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
MAP1LC3B	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
MAP1LC3B	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAP1LC3B	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
MAP1LC3B	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
MAP1LC3B	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
MAP1LC3B	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MAPK3	adenosine triphosphate/metabolism	0.002917059	0.00587238	0.158415842	0.675762622	1	3
MAPK3	caspase 2/metabolism	0	0	0.00990099	0.675762622	1	3
MAPK3	cell survival/drug effects	7.67E-05	0.000224774	0.089108911	0.675762622	1	3
MAPK3	mitochondria/drug effects	0.000719038	0.001650244	0.148514851	0.675762622	1	3
MAPK3	t-2 toxin/toxicity	0	0	0.00990099	0.675762622	1	3
MAPK3	u937 cells	0	0	0.01980198	0.675762622	1	3
MAPK8	PARP1	0.000963614	0.002168629	0.078019802	0.675762622	1	3
MAPK8	adenosine triphosphate/analogs & derivatives	3.72E-09	2.03E-08	0.039405941	0.675762622	1	3
MAPK8	apoptosis	0.003195337	0.006365555	0.134455446	0.675762622	1	3
MAPK8	caspase 2/metabolism	0	0	0.01980198	0.675762622	1	3
MAPK8	endothelial cells/drug effects	1.94E-09	1.09E-08	0.039405941	0.675762622	1	3
MAPK8	mitogen-activated protein kinase 1/metabolism	1.55E-15	1.39E-14	0.01980198	0.675762622	1	3
MAPK8	u937 cells	1.94E-09	1.09E-08	0.039405941	0.675762622	1	3
MAPT	alleles	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
MAPT	axonal transport	8.24E-06	4.01E-05	0.05	0.684648414	1	0
MAPT	cell differentiation/genetics	0.003930343	0.009647206	0.112903226	0.682254817	1	1
MAPT	cells cultured	0.002938736	0.005909467	0.138613861	0.675762622	1	3
MAPT	dopaminergic neurons/cytology	0.003888338	0.009832662	0.1	0.684648414	1	0
MAPT	exons	1.10E-12	1.72E-11	0.016666667	0.684648414	1	0
MAPT	gene expression	1.10E-12	1.72E-11	0.016666667	0.684648414	1	0
MAPT	genetic variation	1.10E-12	1.72E-11	0.016666667	0.684648414	1	0
MAPT	haplotypes	1.10E-12	1.72E-11	0.016666667	0.684648414	1	0
MAPT	induced pluripotent stem cells/cytology	0.001229411	0.002689598	0.138613861	0.675762622	1	3
MAPT	protein isoforms	1.10E-12	1.72E-11	0.016666667	0.684648414	1	0
MAPT	tau proteins/genetics	1.10E-12	1.72E-11	0.016666667	0.684648414	1	0
MEF2C	alpha-synuclein/genetics	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
MEF2C	gene-environment interaction	2.75E-08	2.37E-07	0.033333333	0.684648414	1	0
MEF2C	induced pluripotent stem cells/metabolism	0.004612969	0.008547444	0.247524752	0.675762622	1	3
MEF2C	mitochondria/drug effects	0.001301311	0.002833809	0.148514851	0.675762622	1	3
MEF2C	mutation/drug effects	0	0	0.016666667	0.684648414	1	0
MEF2C	neurons/metabolism	0.000116202	0.00043274	0.1	0.684648414	1	0
MEF2C	oxidative stress	0.000384227	0.001258898	0.083333333	0.684648414	1	0
MEF2C	paraquat/toxicity	0	0	0.016666667	0.684648414	1	0
MEF2C	parkinson disease/genetics	0.002055472	0.003515912	0.197452229	0.704306703	1	4
MEF2C	reactive nitrogen species/metabolism	0	0	0.016666667	0.684648414	1	0
MEF2C	substantia nigra/metabolism	0.003207978	0.008376387	0.116666667	0.684648414	1	0
MFN2	PRKN	0.001385952	0.00300851	0.138613861	0.675762622	1	3
MFN2	cytosol/metabolism	4.98E-06	2.54E-05	0.05	0.684648414	1	0
MFN2	endoplasmic reticulum/metabolism	1.80E-06	9.65E-06	0.033333333	0.684648414	1	0
MFN2	fibroblasts	1.91E-08	1.70E-07	0.033333333	0.684648414	1	0
MFN2	gene expression regulation	4.74E-05	0.000192743	0.05	0.684648414	1	0
MFN2	gtp phosphohydrolases/biosynthesis	1.71E-14	3.53E-13	0.016666667	0.684648414	1	0
MFN2	induced pluripotent stem cells/metabolism	0.001362755	0.00239749	0.165605096	0.704306703	1	4
MFN2	mitophagy/genetics	8.36E-05	0.000322646	0.066666667	0.684648414	1	0
MFN2	parkinson disease/genetics	0.004840196	0.007777901	0.197452229	0.704306703	1	4
MFN2	ubiquitin-protein ligases/genetics	3.07E-05	9.44E-05	0.089108911	0.675762622	1	3
MMP2	PARK7	0.000683797	0.001250632	0.050465458	0.704306703	1	4
MMP2	apoptosis/genetics	0.000357584	0.000855265	0.039405941	0.675762622	1	3
MMP2	autophagy-related protein 7/genetics	8.94E-06	2.93E-05	0.01980198	0.675762622	1	3
MMP2	caspase 3/metabolism	0.002534175	0.005164561	0.039405941	0.675762622	1	3
MMP2	caspase 9/metabolism	0.002534175	0.005164561	0.039405941	0.675762622	1	3
MMP2	endoplasmic reticulum/metabolism	0.004649927	0.007487095	0.062877674	0.704306703	1	4
MMP2	membrane proteins/genetics	0.000436312	0.001030003	0.039405941	0.675762622	1	3
MMP2	microtubule-associated proteins/metabolism	8.94E-06	2.93E-05	0.01980198	0.675762622	1	3
MMP2	mitochondrial proteins/genetics	0.002998582	0.004964356	0.062877674	0.704306703	1	4
MMP2	mitophagy/genetics	0.002083755	0.003563209	0.062877674	0.704306703	1	4
MMP2	muscle development/genetics	8.94E-06	2.93E-05	0.01980198	0.675762622	1	3
MMP2	muscle skeletal/metabolism	8.94E-06	2.93E-05	0.01980198	0.675762622	1	3
MMP2	myoblasts/cytology	8.94E-06	2.93E-05	0.01980198	0.675762622	1	3
MMP2	oxidative stress/genetics	0.000183134	0.000484371	0.039405941	0.675762622	1	3
MSX1	cell line	0.000310442	0.000595486	0.229299363	0.704306703	1	4
MSX1	crispr-cas systems/genetics	0	0	0.01910828	0.704306703	1	4
MSX1	human embryonic stem cells	0	0	0.025477707	0.704306703	1	4
MSX1	msx1 transcription factor/genetics	0	0	0.006369427	0.704306703	1	4
MSX1	mutation	4.03E-05	8.77E-05	0.210191083	0.704306703	1	4
MSX1	odontogenesis/genetics	0	0	0.006369427	0.704306703	1	4
MUTYH	MYOG	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MUTYH	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
MUTYH	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
MUTYH	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
MUTYH	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MUTYH	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MUTYH	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
MUTYH	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MUTYH	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MUTYH	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MUTYH	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
MUTYH	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
MUTYH	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
MUTYH	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MYOG	OPA1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
MYOG	PPARGC1A	0.000296412	0.000716663	0.01980198	0.675762622	1	3
MYOG	RACGAP1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
MYOG	SLC25A4	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MYOG	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MYOG	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
MYOG	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MYOG	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MYOG	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
MYOG	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
MYOG	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
MYOG	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
MYOG	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
NAMPT	NMRK1	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	autophagy	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	dopaminergic neurons/metabolism	0.004641712	0.008570101	0.207920792	0.675762622	1	3
NAMPT	endoplasmic reticulum stress	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	glucosylceramidase/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	induced pluripotent stem cells/pathology	4.80E-09	4.74E-08	0.033333333	0.684648414	1	0
NAMPT	mitochondrial dynamics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	nad/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	niacinamide/analogs & derivatives	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NAMPT	parkinson disease/pathology	0.002834813	0.006457452	0.1	0.6737233	1	2
NAMPT	pyridinium compounds	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NEUROG3	basic helix-loop-helix transcription factors/chemistry	0	0	0.006369427	0.704306703	1	4
NEUROG3	cell line	0.006017887	0.009499708	0.229299363	0.704306703	1	4
NEUROG3	diarrhea/congenital	0	0	0.006369427	0.704306703	1	4
NEUROG3	human embryonic stem cells/metabolism	1.83E-07	5.22E-07	0.063694268	0.704306703	1	4
NEUROG3	intestinal mucosa/cytology	0	0	0.006369427	0.704306703	1	4
NEUROG3	malabsorption syndromes/genetics	0	0	0.006369427	0.704306703	1	4
NEUROG3	mutation	0.001693004	0.0029282	0.210191083	0.704306703	1	4
NEUROG3	nerve tissue proteins/chemistry	0	0	0.006369427	0.704306703	1	4
NEUROG3	organoids/cytology	0	0	0.006369427	0.704306703	1	4
NEUROG3	pancreas/cytology	0	0	0.006369427	0.704306703	1	4
NFE2L2	PRKCA	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	PRKCB	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	PRKCG	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	PRRT2	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	SNCA	0.001646075	0.003517803	0.056915692	0.360232201	2	3
NFE2L2	alpha-synuclein/metabolism	0.002087697	0.004359002	0.142634263	0.675762622	1	3
NFE2L2	brain/drug effects	0.000133262	0.000485659	0.05	0.684648414	1	0
NFE2L2	carbonyl cyanide m-chlorophenyl hydrazone/pharmacology	0.000133262	0.000485659	0.05	0.684648414	1	0
NFE2L2	cellular reprogramming/drug effects	7.21E-06	3.61E-05	0.05	0.684648414	1	0
NFE2L2	gene expression regulation/drug effects	0.000287566	0.000701815	0.087332733	0.675762622	1	3
NFE2L2	induced pluripotent stem cells/drug effects	0.000698095	0.001606237	0.087332733	0.675762622	1	3
NFE2L2	leupeptins/pharmacology	7.21E-06	3.61E-05	0.05	0.684648414	1	0
NFE2L2	lewy bodies/metabolism	0.000133262	0.000485659	0.05	0.684648414	1	0
NFE2L2	microtubule-associated proteins/genetics	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	mitochondrial turnover/drug effects	0.000133262	0.000485659	0.05	0.684648414	1	0
NFE2L2	neurites/metabolism	9.04E-05	0.000252296	0.087332733	0.675762622	1	3
NFE2L2	neurons/drug effects	0.001266578	0.002761485	0.115271527	0.675762622	1	3
NFE2L2	neuroprotective agents/pharmacology	0.005270168	0.009542876	0.142634263	0.675762622	1	3
NFE2L2	nf-e2-related factor 2/genetics	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	nf-e2-related factor 2/metabolism	0.000133262	0.000485659	0.05	0.684648414	1	0
NFE2L2	oxidative stress/drug effects	0.00161738	0.004554729	0.016364699	0.371068466	2	0
NFE2L2	parkinson disease/drug therapy	0.00081334	0.002469004	0.016364699	0.371068466	2	0
NFE2L2	phenanthrenes/pharmacology	7.21E-06	3.61E-05	0.05	0.684648414	1	0
NFE2L2	pluripotent stem cells/metabolism	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	postmortem changes	0.000133262	0.000485659	0.05	0.684648414	1	0
NFE2L2	protein kinase c/genetics	0.000516484	0.001618315	0.05	0.684648414	1	0
NFE2L2	substantia nigra/metabolism	0.002927373	0.004852165	0.128668742	0.704306703	1	4
NFKB1	TNF	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
NFKB1	adenosine triphosphate/metabolism	0.000261865	0.000890819	0.05	0.684648414	1	0
NFKB1	alpha-synuclein/metabolism	0.001714637	0.004737263	0.083333333	0.684648414	1	0
NFKB1	antigen presentation	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
NFKB1	astrocytes/immunology	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
NFKB1	cell membrane/metabolism	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
NFKB1	cell respiration	3.17E-05	0.000131129	0.033333333	0.684648414	1	0
NFKB1	cholesterol/metabolism	1.89E-05	5.98E-05	0.058811881	0.675762622	1	3
NFKB1	cytochrome c group/metabolism	0.000622423	0.001439419	0.087332733	0.675762622	1	3
NFKB1	endothelial cells/drug effects	9.31E-06	3.04E-05	0.058811881	0.675762622	1	3
NFKB1	etoposide/pharmacology	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
NFKB1	fas receptor/metabolism	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
NFKB1	hela cells	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
NFKB1	hla-drb1 chains/chemistry	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
NFKB1	inflammation mediators/metabolism	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
NFKB1	jurkat cells	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
NFKB1	mitomycin/pharmacology	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
NFKB1	nucleic acid synthesis inhibitors/pharmacology	6.34E-08	2.96E-07	0.02970297	0.675762622	1	3
NFKB1	parkinson disease/pathology	0.004951673	0.007951746	0.128668742	0.704306703	1	4
NFKB1	staurosporine/pharmacology	0.000125229	0.000338197	0.058811881	0.675762622	1	3
NFKB1	tumor necrosis factor-alpha/metabolism	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
NGF	aspartic acid/analogs & derivatives	0	0	0.006369427	0.704306703	1	4
NGF	caspases/metabolism	0.00196392	0.00337502	0.095541401	0.704306703	1	4
NGF	cell division/drug effects	0	0	0.006369427	0.704306703	1	4
NGF	cell survival	2.58E-10	9.20E-10	0.025477707	0.704306703	1	4
NGF	cells cultured	0.005557908	0.008841294	0.152866242	0.704306703	1	4
NGF	mitogen-activated protein kinase 1/metabolism	0	0	0.012738854	0.704306703	1	4
NGF	nerve growth factor/pharmacology	0	0	0.006369427	0.704306703	1	4
NGF	neurites/physiology	0	0	0.006369427	0.704306703	1	4
NGF	superior cervical ganglion/cytology	0	0	0.006369427	0.704306703	1	4
NMRK1	autophagy	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NMRK1	dopaminergic neurons/metabolism	0.004641712	0.008570101	0.207920792	0.675762622	1	3
NMRK1	endoplasmic reticulum stress	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NMRK1	glucosylceramidase/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NMRK1	induced pluripotent stem cells/pathology	4.80E-09	4.74E-08	0.033333333	0.684648414	1	0
NMRK1	mitochondrial dynamics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NMRK1	nad/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NMRK1	niacinamide/analogs & derivatives	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NMRK1	parkinson disease/pathology	0.002834813	0.006457452	0.1	0.6737233	1	2
NMRK1	pyridinium compounds	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NOS2	alpha-synuclein/genetics	0.000140559	0.000374859	0.108910891	0.675762622	1	3
NOS2	axonal transport	1.39E-06	7.58E-06	0.05	0.684648414	1	0
NOS2	axons/metabolism	1.06E-07	6.91E-07	0.033333333	0.684648414	1	0
NOS2	cell line	0.004816425	0.008798757	0.168316832	0.675762622	1	3
NOS2	induced pluripotent stem cells/metabolism	0.00083398	0.00150223	0.165605096	0.704306703	1	4
NOS2	microtubules/genetics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NOS2	mitochondria/genetics	0.00255435	0.006777896	0.15	0.684648414	1	0
NOS2	mutation missense	2.76E-05	0.00011708	0.05	0.684648414	1	0
NOS2	nitric oxide/genetics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NOS2	parkinson disease/genetics	0.003263923	0.005366331	0.197452229	0.704306703	1	4
NOS2	protein transport/genetics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NOS2	tubulin/genetics	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
NPC1	aging/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	biological transport active/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	brain/metabolism	0.000203814	0.000620316	0.057142857	0.6737233	1	2
NPC1	cell survival/genetics	6.28E-05	0.000211523	0.042857143	0.6737233	1	2
NPC1	cholesterol/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	drosophila proteins/genetics	7.58E-05	0.000223325	0.079207921	0.675762622	1	3
NPC1	filipin/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	gene expression regulation developmental/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	genes lethal/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	inclusion bodies/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	intracellular membranes/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	mutation/genetics	0.00447086	0.008309562	0.108910891	0.675762622	1	3
NPC1	nerve degeneration/genetics	3.31E-05	0.000101416	0.069306931	0.675762622	1	3
NPC1	niemann-pick diseases/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	organelles/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	photoreceptor cells invertebrate/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NPC1	retinal diseases/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
NRF1	PPARGC1A	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	TFAM	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	TNF	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
NRF1	acyl-coa dehydrogenases/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	dopaminergic neurons/ultrastructure	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	electron transport complex i/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	frontal lobe/pathology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	gene expression regulation/drug effects	1.59E-05	7.14E-05	0.033333333	0.684648414	1	0
NRF1	micrornas/genetics	7.54E-06	3.71E-05	0.033333333	0.684648414	1	0
NRF1	mitochondrial proteins/genetics	0.000440857	0.001422781	0.05	0.684648414	1	0
NRF1	mitochondrial turnover/physiology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	neural stem cells	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	nuclear respiratory factor 1/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	parkinson disease/pathology	0.000192697	0.000505493	0.069306931	0.675762622	1	3
NRF1	rotenone/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
NRF1	tumor necrosis factor-alpha/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
OPA1	PTPN2	0.002336341	0.006297495	0.066101695	0.684648414	1	0
OPA1	RACGAP1	0.004435751	0.008273943	0.058811881	0.675762622	1	3
OPA1	SLC25A4	0.001032726	0.002305124	0.02970297	0.675762622	1	3
OPA1	SOD1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
OPA1	SOD2	0.00100923	0.001805018	0.037971583	0.704306703	1	4
OPA1	SQSTM1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
OPA1	UTRN	0.001032726	0.002305124	0.02970297	0.675762622	1	3
OPA1	VDAC1	0.001032726	0.002305124	0.02970297	0.675762622	1	3
OPA1	cell differentiation/drug effects	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
OPA1	dopaminergic neurons/drug effects	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
OPA1	gtp phosphohydrolases/genetics	1.74E-11	2.62E-10	0.000564972	0.371068466	2	0
OPA1	induced pluripotent stem cells/drug effects	0.000544654	0.0010066	0.056591487	0.704306703	1	4
OPA1	lysosomes/drug effects	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
OPA1	mutation/genetics	0.000721419	0.002210121	0.015819209	0.371068466	2	0
OPA1	necrosis	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
OPA1	neostriatum/metabolism	1.06E-07	6.91E-07	0.033333333	0.684648414	1	0
OPA1	nerve net/metabolism	1.06E-07	6.91E-07	0.033333333	0.684648414	1	0
OPA1	neural stem cells/drug effects	0.000799285	0.001450088	0.056591487	0.704306703	1	4
OPA1	neurites/metabolism	0.003586832	0.009230053	0.098305085	0.684648414	1	0
OPA1	neuromuscular junction/genetics	0.001032726	0.002305124	0.02970297	0.675762622	1	3
OPA1	small molecule libraries/pharmacology	8.80E-06	4.20E-05	0.033333333	0.684648414	1	0
OPA1	synapses/metabolism	0.000145069	0.000521253	0.066101695	0.684648414	1	0
OSMR	STAT5A	0	0	0.006369427	0.704306703	1	4
OSMR	cell line	0.006017887	0.009499708	0.229299363	0.704306703	1	4
OSMR	crispr-cas systems/genetics	0	0	0.01910828	0.704306703	1	4
OSMR	homologous recombination	0	0	0.006369427	0.704306703	1	4
OSMR	homozygote	0	0	0.012738854	0.704306703	1	4
OSMR	human embryonic stem cells/metabolism	1.83E-07	5.22E-07	0.063694268	0.704306703	1	4
OSMR	kruppel-like transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
OSMR	mutation/genetics	8.93E-06	2.09E-05	0.089171975	0.704306703	1	4
OSMR	oncostatin m receptor beta subunit/genetics	0	0	0.006369427	0.704306703	1	4
OXR1	TARDBP	2.89E-14	4.38E-13	0.028571429	0.6737233	1	2
OXR1	amyotrophic lateral sclerosis/genetics	1.14E-09	1.02E-08	0.042857143	0.6737233	1	2
OXR1	cytoplasm/metabolism	0	0	0.014285714	0.6737233	1	2
OXR1	dna-binding proteins/genetics	2.78E-11	2.97E-10	0.042857143	0.6737233	1	2
OXR1	mitochondrial proteins/genetics	3.68E-06	1.57E-05	0.057142857	0.6737233	1	2
OXR1	motor neurons/metabolism	1.14E-09	1.02E-08	0.042857143	0.6737233	1	2
OXR1	muscles/innervation	0	0	0.014285714	0.6737233	1	2
OXR1	mutation missense	6.83E-06	2.76E-05	0.057142857	0.6737233	1	2
OXR1	neuromuscular junction/metabolism	2.89E-14	4.38E-13	0.028571429	0.6737233	1	2
OXR1	protein transport	0	0	0.014285714	0.6737233	1	2
P2RX7	TNF	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
P2RX7	chromones/pharmacology	0	0	0.00990099	0.675762622	1	3
P2RX7	cytosol/drug effects	0	0	0.00990099	0.675762622	1	3
P2RX7	drug resistance neoplasm	7.00E-12	4.86E-11	0.01980198	0.675762622	1	3
P2RX7	gene expression regulation neoplastic/drug effects	1.55E-15	1.39E-14	0.01980198	0.675762622	1	3
P2RX7	hl-60 cells	2.47E-10	1.50E-09	0.02970297	0.675762622	1	3
P2RX7	membrane glycoproteins/pharmacokinetics	0	0	0.00990099	0.675762622	1	3
P2RX7	morpholines/pharmacology	0	0	0.00990099	0.675762622	1	3
P2RX7	nf-kappa b/metabolism	3.05E-13	2.38E-12	0.01980198	0.675762622	1	3
P2RX7	phosphoinositide-3 kinase inhibitors	0	0	0.00990099	0.675762622	1	3
P2RX7	tumor necrosis factor-alpha/pharmacokinetics	0	0	0.00990099	0.675762622	1	3
PARK7	SIRT1	4.80E-09	4.74E-08	0.05	0.684648414	1	0
PARK7	TNS1	4.12E-05	0.000168133	0.05	0.684648414	1	0
PARK7	apoptosis/genetics	0.00045589	0.001073429	0.078019802	0.675762622	1	3
PARK7	autophagy-related protein 7/genetics	1.28E-05	4.15E-05	0.03960396	0.675762622	1	3
PARK7	caspase 3/metabolism	0.003037538	0.006092407	0.078019802	0.675762622	1	3
PARK7	caspase 9/metabolism	0.003037538	0.006092407	0.078019802	0.675762622	1	3
PARK7	cell survival	4.12E-05	0.000168133	0.05	0.684648414	1	0
PARK7	dopaminergic neurons/metabolism	0.003717926	0.00607731	0.086811278	0.395836357	2	4
PARK7	endoplasmic reticulum/metabolism	0.005469507	0.008720363	0.122551991	0.704306703	1	4
PARK7	genes recessive	1.96E-06	1.04E-05	0.05	0.684648414	1	0
PARK7	genetic predisposition to disease	0.001456964	0.003156996	0.115271527	0.675762622	1	3
PARK7	hydrogen peroxide/pharmacology	0.002834813	0.006457452	0.08447205	0.6737233	1	2
PARK7	membrane potential mitochondrial	0.000930286	0.00209622	0.115271527	0.675762622	1	3
PARK7	membrane proteins/genetics	0.000552757	0.001282938	0.078019802	0.675762622	1	3
PARK7	mesenchymal stem cells/metabolism	4.12E-05	0.000168133	0.05	0.684648414	1	0
PARK7	microtubule-associated proteins/metabolism	1.28E-05	4.15E-05	0.03960396	0.675762622	1	3
PARK7	mitochondria/metabolism	0.00105347	0.00234854	0.011358524	0.055923458	4	3
PARK7	mitochondrial proteins/genetics	0.003575407	0.005854538	0.122551991	0.704306703	1	4
PARK7	mitophagy/genetics	0.002512954	0.004222392	0.122551991	0.704306703	1	4
PARK7	muscle development/genetics	1.28E-05	4.15E-05	0.03960396	0.675762622	1	3
PARK7	muscle skeletal/metabolism	1.28E-05	4.15E-05	0.03960396	0.675762622	1	3
PARK7	myoblasts/cytology	1.28E-05	4.15E-05	0.03960396	0.675762622	1	3
PARK7	neural stem cells/metabolism	0.004957485	0.009026251	0.220278354	0.675762622	1	3
PARK7	oxidative stress/genetics	0.000238514	0.000590701	0.078019802	0.675762622	1	3
PARK7	oxidopamine	0.000694847	0.002149189	0.098305085	0.684648414	1	0
PARK7	oxidopamine/pharmacology	0.000516484	0.001618315	0.098305085	0.684648414	1	0
PARK7	parkinson disease/diagnosis	0.003238547	0.008429292	0.098305085	0.684648414	1	0
PARK7	phenotype	0.00308306	0.00782877	0.041459545	0.36812785	2	1
PARK7	pluripotent stem cells/cytology	1.96E-06	1.04E-05	0.05	0.684648414	1	0
PARK7	protein deglycase dj-1/metabolism	4.80E-09	4.74E-08	0.05	0.684648414	1	0
PARK7	tyrosine 3-monooxygenase/genetics	1.96E-06	1.04E-05	0.05	0.684648414	1	0
PARK7	wharton jelly/cytology	4.12E-05	0.000168133	0.05	0.684648414	1	0
PARP1	adenosine triphosphate/analogs & derivatives	0.00184059	0.003863041	0.078019802	0.675762622	1	3
PARP1	adenosine triphosphate/biosynthesis	5.13E-06	1.81E-05	0.03960396	0.675762622	1	3
PARP1	alpha-chlorohydrin/toxicity	5.13E-06	1.81E-05	0.03960396	0.675762622	1	3
PARP1	cell survival/drug effects	0.00045558	0.001072931	0.001923621	0.155527348	3	3
PARP1	chemosterilants/toxicity	5.13E-06	1.81E-05	0.03960396	0.675762622	1	3
PARP1	dna fragmentation/drug effects	0.000751275	0.001718801	0.03960396	0.675762622	1	3
PARP1	endothelial cells/drug effects	0.001505636	0.003243114	0.078019802	0.675762622	1	3
PARP1	intracellular membranes/metabolism	0.000451281	0.000845496	0.062877674	0.704306703	1	4
PARP1	membrane potential mitochondrial/drug effects	0.000293468	0.000713025	0.001292701	0.155527348	3	3
PARP1	mitogen-activated protein kinase 1/metabolism	2.09E-05	6.56E-05	0.03960396	0.675762622	1	3
PCNA	RAF1	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	caspase 8/metabolism	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	caspase 9/metabolism	3.34E-06	1.21E-05	0.01980198	0.675762622	1	3
PCNA	cytochrome p-450 cyp3a/metabolism	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	cytotoxins/chemistry	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	dna fragmentation/drug effects	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	dose-response relationship drug	0.005131496	0.009307242	0.069306931	0.675762622	1	3
PCNA	hep g2 cells	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	phosphatidylserines/metabolism	7.15E-08	3.30E-07	0.01980198	0.675762622	1	3
PCNA	plant extracts/toxicity	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	plant roots/chemistry	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PCNA	water/chemistry	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
PI3	PRAM1	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	anti-inflammatory agents/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	antioxidants/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	cachexia/etiology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	caspases/metabolism	0.001820581	0.003843069	0.03960396	0.675762622	1	3
PI3	cell death	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	cell survival	4.52E-06	1.60E-05	0.01980198	0.675762622	1	3
PI3	cytokines/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	inflammation/drug therapy	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	leukocytes mononuclear/drug effects	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	neoplasms/complications	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	oxidants/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	oxidative stress/drug effects	0.003172487	0.006322346	0.059405941	0.675762622	1	3
PI3	plant extracts	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PI3	triterpenes/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PIK3CA	PTEN	0.00062966	0.001455846	6.32E-06	0.004574958	6	3
PIK3CA	apoptosis	0.000249791	0.000615413	0.003824156	0.155527348	3	3
PIK3CA	cell proliferation/drug effects	0.001661119	0.003541891	0.008670867	0.360232201	2	3
PIK3CA	etoposide/pharmacology	0.001076908	0.002392471	0.059405941	0.675762622	1	3
PIK3CA	fas receptor/metabolism	0.001076908	0.002392471	0.059405941	0.675762622	1	3
PIK3CA	hela cells	0.001076908	0.002392471	0.059405941	0.675762622	1	3
PIK3CA	jurkat cells	0.001076908	0.002392471	0.059405941	0.675762622	1	3
PIK3CA	mitomycin/pharmacology	0.001076908	0.002392471	0.059405941	0.675762622	1	3
PIK3CA	nucleic acid synthesis inhibitors/pharmacology	0.001076908	0.002392471	0.059405941	0.675762622	1	3
PIK3CA	proto-oncogene proteins c-akt/genetics	0.000664022	0.001216307	0.075208231	0.704306703	1	4
PIK3CA	reactive oxygen species	0.002214162	0.003751294	0.075208231	0.704306703	1	4
PIK3CA	rna messenger/genetics	0.001867138	0.003220814	0.075208231	0.704306703	1	4
PINK1	PRKN	0.002915393	0.00587238	0.043789922	0.017151793	5	3
PINK1	PTEN	0.001163716	0.002985593	0.00831202	0.153812767	3	2
PINK1	RACGAP1	0.004794632	0.00878841	0.023762376	0.360232201	2	3
PINK1	TNS1	0.00091626	0.001644481	0.101910828	0.704306703	1	4
PINK1	calcium channel blockers/chemistry	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	calcium channels t-type/metabolism	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	cysteine	0.002399166	0.006420281	0.233333333	0.684648414	1	0
PINK1	dna mitochondrial/metabolism	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	dopamine/metabolism	0.002875321	0.004773377	0.081386828	0.395836357	2	4
PINK1	dopaminergic neurons/metabolism	0.001041805	0.001862688	0.042851496	0.022707082	5	4
PINK1	drosophila proteins/metabolism	0.001846066	0.003185439	0.194022538	0.704306703	1	4
PINK1	homeostasis/drug effects	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	hypothalamus/metabolism	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	indoles/therapeutic use	0.000698095	0.001606237	0.158415842	0.675762622	1	3
PINK1	induced pluripotent stem cells	2.21E-05	6.92E-05	0.012104068	0.155527348	3	3
PINK1	induced pluripotent stem cells/cytology	0.001315349	0.002863236	0.043789922	0.017151793	5	3
PINK1	lipid metabolism	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	lung/cytology	0.000603458	0.001110908	0.101910828	0.704306703	1	4
PINK1	mesencephalon/cytology	0.000603458	0.001110908	0.101910828	0.704306703	1	4
PINK1	mesenchymal stem cells/metabolism	0.00091626	0.001644481	0.101910828	0.704306703	1	4
PINK1	mitochondria/metabolism	0.000398196	0.000945554	0.010203243	7.54E-06	10	3
PINK1	mitophagy	0.000332692	0.000800827	0.02724785	0.155527348	3	3
PINK1	mitophagy/physiology	0.003248811	0.005351373	0.194022538	0.704306703	1	4
PINK1	muscle skeletal/pathology	0.004612969	0.008547444	0.158415842	0.675762622	1	3
PINK1	nerve degeneration/complications	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	neural stem cells/metabolism	0.005146143	0.008230421	0.151193243	0.395836357	2	4
PINK1	neuronal outgrowth/drug effects	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	neurons/cytology	4.30E-05	0.00013027	0.02724785	0.155527348	3	3
PINK1	neurons/metabolism	0.002808008	0.004682321	0.108011459	0.18130336	3	4
PINK1	neuropeptides/metabolism	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	neuroprotection	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	organ specificity	0.000603458	0.001110908	0.101910828	0.704306703	1	4
PINK1	parkinson disease/metabolism	0.003229555	0.008427346	0.020236108	0.001226504	7	0
PINK1	phenols/therapeutic use	0.000698095	0.001606237	0.158415842	0.675762622	1	3
PINK1	phenotype	0.004688128	0.008654334	0.070345698	0.055923458	4	3
PINK1	protein kinases	0.000138015	0.00037025	0.158415842	0.675762622	1	3
PINK1	protein kinases/genetics	0.001640344	0.00461622	0.010637054	0.163189624	3	0
PINK1	protein kinases/metabolism	0.000247668	0.000847461	0.002052765	0.059834132	4	0
PINK1	respiration	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	rho gtp-binding proteins/metabolism	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	rotenone/toxicity	0.00132664	0.002338079	0.101910828	0.704306703	1	4
PINK1	serine/metabolism	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	sirolimus/therapeutic use	0.000698095	0.001606237	0.158415842	0.675762622	1	3
PINK1	stress physiological	0.000362423	0.00086665	0.023762376	0.360232201	2	3
PINK1	ubiquinone/therapeutic use	0.000698095	0.001606237	0.158415842	0.675762622	1	3
PINK1	ubiquitin-protein ligases/deficiency	0.001266578	0.002761485	0.158415842	0.675762622	1	3
PINK1	ubiquitin-protein ligases/genetics	0.00079869	0.001816978	0.033220928	0.055923458	4	3
PINK1	ubiquitin-protein ligases/metabolism	9.21E-06	3.01E-05	0.00180666	0.004574958	6	3
PINK1	ubiquitin/chemistry	0.000603458	0.001110908	0.101910828	0.704306703	1	4
PINK1	wharton jelly/cytology	0.00091626	0.001644481	0.101910828	0.704306703	1	4
PPARGC1A	RACGAP1	0.001673184	0.003564553	0.039405941	0.675762622	1	3
PPARGC1A	SLC25A4	0.000296412	0.000716663	0.01980198	0.675762622	1	3
PPARGC1A	SOD1	0.000296412	0.000716663	0.01980198	0.675762622	1	3
PPARGC1A	SOD2	0.003864335	0.007374722	0.039405941	0.675762622	1	3
PPARGC1A	SQSTM1	0.000296412	0.000716663	0.01980198	0.675762622	1	3
PPARGC1A	TFAM	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	TNF	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
PPARGC1A	UTRN	0.000296412	0.000716663	0.01980198	0.675762622	1	3
PPARGC1A	VDAC1	0.000296412	0.000716663	0.01980198	0.675762622	1	3
PPARGC1A	acyl-coa dehydrogenases/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	dopaminergic neurons/ultrastructure	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	electron transport complex i/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	frontal lobe/pathology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	gene expression regulation/drug effects	1.59E-05	7.14E-05	0.033333333	0.684648414	1	0
PPARGC1A	micrornas/genetics	7.54E-06	3.71E-05	0.033333333	0.684648414	1	0
PPARGC1A	mitochondrial proteins/genetics	0.000440857	0.001422781	0.05	0.684648414	1	0
PPARGC1A	mitochondrial turnover/physiology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	neural stem cells	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	neuromuscular junction/genetics	0.000296412	0.000716663	0.01980198	0.675762622	1	3
PPARGC1A	nuclear respiratory factor 1/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	rotenone/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PPARGC1A	tumor necrosis factor-alpha/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRAM1	anti-inflammatory agents/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	antioxidants/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	cachexia/etiology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	caspases/metabolism	0.001820581	0.003843069	0.03960396	0.675762622	1	3
PRAM1	cell death	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	cell survival	4.52E-06	1.60E-05	0.01980198	0.675762622	1	3
PRAM1	cytokines/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	inflammation/drug therapy	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	leukocytes mononuclear/drug effects	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	neoplasms/complications	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	oxidants/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	oxidative stress/drug effects	0.003172487	0.006322346	0.059405941	0.675762622	1	3
PRAM1	plant extracts	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRAM1	triterpenes/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
PRKCA	PRKCB	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	PRKCG	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	PRRT2	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	alpha-synuclein/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
PRKCA	cell differentiation/genetics	0.000276783	0.000677928	0.079207921	0.675762622	1	3
PRKCA	microtubule-associated proteins/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	neurites/metabolism	0.000177032	0.000621894	0.05	0.684648414	1	0
PRKCA	nf-e2-related factor 2/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	parkinson disease/drug therapy	0.0026219	0.006119054	0.071428571	0.6737233	1	2
PRKCA	pluripotent stem cells/metabolism	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	protein kinase c/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCA	substantia nigra/metabolism	0.000140559	0.000374859	0.069306931	0.675762622	1	3
PRKCB	PRKCG	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCB	PRRT2	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCB	alpha-synuclein/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
PRKCB	cell differentiation/genetics	0.000276783	0.000677928	0.079207921	0.675762622	1	3
PRKCB	microtubule-associated proteins/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCB	neurites/metabolism	0.000177032	0.000621894	0.05	0.684648414	1	0
PRKCB	nf-e2-related factor 2/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCB	parkinson disease/drug therapy	0.0026219	0.006119054	0.071428571	0.6737233	1	2
PRKCB	pluripotent stem cells/metabolism	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCB	protein kinase c/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCB	substantia nigra/metabolism	0.000140559	0.000374859	0.069306931	0.675762622	1	3
PRKCG	PRRT2	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCG	alpha-synuclein/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
PRKCG	cell differentiation/genetics	0.000276783	0.000677928	0.079207921	0.675762622	1	3
PRKCG	microtubule-associated proteins/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCG	neurites/metabolism	0.000177032	0.000621894	0.05	0.684648414	1	0
PRKCG	nf-e2-related factor 2/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCG	parkinson disease/drug therapy	0.0026219	0.006119054	0.071428571	0.6737233	1	2
PRKCG	pluripotent stem cells/metabolism	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCG	protein kinase c/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRKCG	substantia nigra/metabolism	0.000140559	0.000374859	0.069306931	0.675762622	1	3
PRKN	STOML2	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	alpha-synuclein/metabolism	0.000532786	0.000986069	0.06340957	0.395836357	2	4
PRKN	blood proteins/metabolism	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	brain/drug effects	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	calcium channel blockers/chemistry	0.000503858	0.00093694	0.089171975	0.704306703	1	4
PRKN	calcium channels t-type/metabolism	0.000503858	0.00093694	0.089171975	0.704306703	1	4
PRKN	carbonyl cyanide m-chlorophenyl hydrazone/pharmacology	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	cell differentiation/physiology	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	cellular reprogramming	0.003052699	0.005051476	0.170912951	0.704306703	1	4
PRKN	chlorides/metabolism	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	dna mitochondrial/metabolism	0.000477673	0.001121327	0.138613861	0.675762622	1	3
PRKN	dopamine/metabolism	0.001069854	0.001909203	0.06340957	0.395836357	2	4
PRKN	dopaminergic neurons/cytology	0.000613457	0.001420191	0.033538041	0.155527348	3	3
PRKN	dopaminergic neurons/metabolism	0.000232977	0.00045962	0.023704323	0.022707082	5	4
PRKN	drosophila proteins/metabolism	0.000737149	0.001342979	0.170912951	0.704306703	1	4
PRKN	electron transport complex i/metabolism	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	environmental pollutants/metabolism	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	fibroblasts	0.003787378	0.006188074	0.170912951	0.704306703	1	4
PRKN	genes recessive	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	genetic predisposition to disease	0.00090002	0.002030121	0.049690969	0.360232201	2	3
PRKN	genome human	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	glucosylceramidase/genetics	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	gtp phosphohydrolases/biosynthesis	0.001385952	0.00300851	0.138613861	0.675762622	1	3
PRKN	homeostasis/drug effects	0.000503858	0.00093694	0.089171975	0.704306703	1	4
PRKN	hyaluronan receptors/metabolism	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	induced pluripotent stem cells/cytology	0.000306004	0.000738872	0.023860478	0.017151793	5	3
PRKN	induced pluripotent stem cells/drug effects	0.002841097	0.005747064	0.049690969	0.360232201	2	3
PRKN	lewy bodies/metabolism	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	manganese compounds/metabolism	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	manganese poisoning/genetics	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	mesencephalon/cytology	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	metabolome	0.000104407	0.000285861	0.138613861	0.675762622	1	3
PRKN	mitochondria/metabolism	0.000417797	0.000990155	0.012126215	4.33E-05	9	3
PRKN	mitochondrial turnover/drug effects	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	mitophagy/genetics	0.00175174	0.003028241	0.06340957	0.395836357	2	4
PRKN	mitophagy/physiology	0.001412662	0.002479088	0.170912951	0.704306703	1	4
PRKN	muscle skeletal/pathology	0.002113975	0.00440206	0.138613861	0.675762622	1	3
PRKN	mutation	9.66E-06	3.15E-05	0.001971327	0.000227327	8	3
PRKN	neural stem cells/cytology	0.000519697	0.001210589	0.049690969	0.360232201	2	3
PRKN	neuronal outgrowth/drug effects	0.000503858	0.00093694	0.089171975	0.704306703	1	4
PRKN	nf-e2-related factor 2/metabolism	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	organ specificity	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	parkinson disease secondary/chemically induced	0.000737149	0.001342979	0.089171975	0.704306703	1	4
PRKN	parkinson disease/diagnosis	5.27E-05	0.000158479	0.018019802	0.360232201	2	3
PRKN	parkinson disease/etiology	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	parkinson disease/genetics	0.000472528	0.000882111	0.034117884	0.006469601	6	4
PRKN	parkinson disease/metabolism	0.00600312	0.009499462	0.156800954	0.18130336	3	4
PRKN	phenotype	0.001498381	0.003232261	0.043910234	0.055923458	4	3
PRKN	pluripotent stem cells/cytology	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	postmortem changes	0.003054205	0.00611683	0.138613861	0.675762622	1	3
PRKN	protein kinases/genetics	7.25E-06	2.54E-05	0.008001372	0.155527348	3	3
PRKN	rotenone/toxicity	0.000503858	0.00093694	0.089171975	0.704306703	1	4
PRKN	tyrosine 3-monooxygenase/genetics	0.000849282	0.00192244	0.138613861	0.675762622	1	3
PRKN	ubiquitin-protein ligases	0.005557908	0.008841294	0.170912951	0.704306703	1	4
PRKN	ubiquitin-protein ligases/deficiency	0.000477673	0.001121327	0.138613861	0.675762622	1	3
PRKN	ubiquitin-protein ligases/genetics	0.00121879	0.003487496	0.000757023	0.005097868	6	0
PRKN	ubiquitin-protein ligases/metabolism	0.002186738	0.004546629	0.043910234	0.055923458	4	3
PRRT2	alpha-synuclein/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
PRRT2	cell differentiation/genetics	0.000276783	0.000677928	0.079207921	0.675762622	1	3
PRRT2	microtubule-associated proteins/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRRT2	neurites/metabolism	0.000177032	0.000621894	0.05	0.684648414	1	0
PRRT2	nf-e2-related factor 2/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRRT2	parkinson disease/drug therapy	0.0026219	0.006119054	0.071428571	0.6737233	1	2
PRRT2	pluripotent stem cells/metabolism	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRRT2	protein kinase c/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
PRRT2	substantia nigra/metabolism	0.000140559	0.000374859	0.069306931	0.675762622	1	3
PTEN	dose-response relationship drug	0.000678529	0.002101897	0.066101695	0.684648414	1	0
PTEN	fibroblasts/cytology	0.000211697	0.000732962	0.066101695	0.684648414	1	0
PTEN	homozygote	3.12E-07	1.84E-06	0.033333333	0.684648414	1	0
PTEN	indoles/therapeutic use	3.16E-10	4.08E-09	0.033333333	0.684648414	1	0
PTEN	lung/cytology	3.12E-07	1.84E-06	0.033333333	0.684648414	1	0
PTEN	muscle skeletal/pathology	5.16E-06	2.12E-05	0.042857143	0.6737233	1	2
PTEN	mutation missense	0.003515773	0.00884333	0.095187731	0.682254817	1	1
PTEN	neurons/cytology	9.91E-08	6.52E-07	0.005649718	0.371068466	2	0
PTEN	phenols/therapeutic use	3.16E-10	4.08E-09	0.033333333	0.684648414	1	0
PTEN	sirolimus/therapeutic use	3.16E-10	4.08E-09	0.033333333	0.684648414	1	0
PTEN	ubiquinone/therapeutic use	3.16E-10	4.08E-09	0.033333333	0.684648414	1	0
PTEN	ubiquitin-protein ligases	0.000966671	0.002555925	0.08447205	0.6737233	1	2
PTEN	ubiquitin/chemistry	3.12E-07	1.84E-06	0.033333333	0.684648414	1	0
PTPN2	cell differentiation/drug effects	5.52E-05	0.000222049	0.033333333	0.684648414	1	0
PTPN2	dopaminergic neurons/cytology	0.00286331	0.005784481	0.115841584	0.675762622	1	3
PTPN2	dopaminergic neurons/drug effects	5.52E-05	0.000222049	0.033333333	0.684648414	1	0
PTPN2	genome human	9.07E-05	0.000347002	0.033333333	0.684648414	1	0
PTPN2	glucosylceramidase/genetics	9.07E-05	0.000347002	0.033333333	0.684648414	1	0
PTPN2	gtp phosphohydrolases/genetics	0.002336341	0.006297495	0.066101695	0.684648414	1	0
PTPN2	induced pluripotent stem cells/drug effects	0.000131809	0.000354735	0.058811881	0.675762622	1	3
PTPN2	leucine-rich repeat serine-threonine protein kinase-2/genetics	0.000111744	0.000305105	0.078019802	0.675762622	1	3
PTPN2	lysosomes/drug effects	5.52E-05	0.000222049	0.033333333	0.684648414	1	0
PTPN2	mitophagy	0.000784513	0.001786217	0.097029703	0.675762622	1	3
PTPN2	necrosis	5.52E-05	0.000222049	0.033333333	0.684648414	1	0
PTPN2	neural stem cells/cytology	1.36E-05	4.39E-05	0.058811881	0.675762622	1	3
PTPN2	neural stem cells/drug effects	0.000208597	0.000519918	0.058811881	0.675762622	1	3
PTPN2	neurogenesis	0.003315763	0.008624781	0.066101695	0.684648414	1	0
PTPN2	neuroprotective agents/pharmacology	0.001606218	0.00343532	0.097029703	0.675762622	1	3
PTPN2	parkinson disease/pathology	0.001000521	0.00179001	0.087457129	0.704306703	1	4
PTPN2	small molecule libraries/pharmacology	5.52E-05	0.000222049	0.033333333	0.684648414	1	0
PTPN2	ubiquitin-protein ligases/genetics	0.001925901	0.003318117	0.111709946	0.704306703	1	4
RACGAP1	RHOT1	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RACGAP1	SLC25A4	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
RACGAP1	SOD1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
RACGAP1	SOD2	0.001856702	0.003893107	0.039405941	0.675762622	1	3
RACGAP1	SQSTM1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
RACGAP1	UTRN	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
RACGAP1	VDAC1	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
RACGAP1	adp ribose transferases/pharmacology	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	amides/pharmacology	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	botulinum toxins/pharmacology	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	mitochondrial proteins/metabolism	0.000384227	0.001258898	0.083333333	0.684648414	1	0
RACGAP1	myocytes cardiac/drug effects	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	neural stem cells/metabolism	4.60E-05	0.000187214	0.1	0.684648414	1	0
RACGAP1	neuromuscular junction/genetics	9.99E-05	0.00027557	0.01980198	0.675762622	1	3
RACGAP1	phospholipid transfer proteins/metabolism	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	protein kinases/metabolism	2.19E-05	9.62E-05	0.066666667	0.684648414	1	0
RACGAP1	pyridines/pharmacology	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	respiration	0	0	0.016666667	0.684648414	1	0
RACGAP1	rho gtp-binding proteins/antagonists & inhibitors	4.41E-06	1.07E-05	0.037971583	0.704306703	1	4
RACGAP1	rho gtp-binding proteins/genetics	6.52E-07	3.77E-06	0.05	0.684648414	1	0
RACGAP1	rho-associated kinases/antagonists & inhibitors	4.61E-09	1.50E-08	0.01910828	0.704306703	1	4
RACGAP1	serine/metabolism	0	0	0.016666667	0.684648414	1	0
RAF1	caspase 8/metabolism	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	caspase 9/metabolism	3.34E-06	1.21E-05	0.01980198	0.675762622	1	3
RAF1	cytochrome p-450 cyp3a/metabolism	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	cytotoxins/chemistry	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	dna fragmentation/drug effects	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	dose-response relationship drug	0.005131496	0.009307242	0.069306931	0.675762622	1	3
RAF1	hep g2 cells	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	phosphatidylserines/metabolism	7.15E-08	3.30E-07	0.01980198	0.675762622	1	3
RAF1	plant extracts/toxicity	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	plant roots/chemistry	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RAF1	water/chemistry	8.81E-11	5.47E-10	0.00990099	0.675762622	1	3
RHOT1	antiparkinson agents/pharmacology	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RHOT1	biomarkers/metabolism	0.000304892	0.001031187	0.098305085	0.684648414	1	0
RHOT1	calcium/metabolism	0.005131496	0.009307242	0.169426943	0.675762622	1	3
RHOT1	cytosol/metabolism	0.003292695	0.007387198	0.124862989	0.6737233	1	2
RHOT1	drosophila proteins/antagonists & inhibitors	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RHOT1	endoplasmic reticulum/genetics	3.61E-06	1.89E-05	0.05	0.684648414	1	0
RHOT1	fibroblasts	0.000762885	0.002317561	0.098305085	0.684648414	1	0
RHOT1	hek293 cells	1.36E-05	4.39E-05	0.087332733	0.675762622	1	3
RHOT1	homeostasis/genetics	3.61E-06	1.89E-05	0.05	0.684648414	1	0
RHOT1	induced pluripotent stem cells	0.000111744	0.000305105	0.115271527	0.675762622	1	3
RHOT1	mitochondria/genetics	0.004127266	0.007751606	0.246444644	0.675762622	1	3
RHOT1	mitochondrial dynamics/genetics	3.61E-06	1.89E-05	0.05	0.684648414	1	0
RHOT1	mitochondrial proteins/antagonists & inhibitors	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RHOT1	mitochondrial proteins/genetics	0.002176124	0.004525425	0.142634263	0.675762622	1	3
RHOT1	mitochondrial proteins/metabolism	0.000591353	0.001089572	0.128668742	0.704306703	1	4
RHOT1	mitophagy/genetics	0.001481166	0.00320625	0.142634263	0.675762622	1	3
RHOT1	nerve degeneration/drug therapy	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RHOT1	neural stem cells/metabolism	0.000208597	0.000519918	0.169426943	0.675762622	1	3
RHOT1	neurons/drug effects	0.000275721	0.000676697	0.115271527	0.675762622	1	3
RHOT1	neurons/metabolism	0.003700868	0.006051767	0.213478529	0.704306703	1	4
RHOT1	parkinson disease/drug therapy	0.001046397	0.002333726	0.142634263	0.675762622	1	3
RHOT1	parkinson disease/genetics	0.001309345	0.002310246	0.099706026	0.395836357	2	4
RHOT1	protein kinases/metabolism	0.000111744	0.000305105	0.115271527	0.675762622	1	3
RHOT1	respiration	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RHOT1	rho gtp-binding proteins/antagonists & inhibitors	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RHOT1	rho gtp-binding proteins/genetics	5.98E-08	3.97E-07	0.0050263	0.371068466	2	0
RHOT1	serine/metabolism	4.48E-07	2.61E-06	0.05	0.684648414	1	0
RMDN3	VAPB	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
RMDN3	adenosine triphosphate/metabolism	0.001173863	0.003382612	0.05	0.684648414	1	0
RMDN3	amyotrophic lateral sclerosis/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
RMDN3	calcium/metabolism	0.002154272	0.005876463	0.05	0.684648414	1	0
RMDN3	cations divalent/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
RMDN3	cell line tumor	0.000762885	0.002317561	0.05	0.684648414	1	0
RMDN3	endoplasmic reticulum/metabolism	0.000133262	0.000485659	0.033333333	0.684648414	1	0
RMDN3	gene expression	0.001805441	0.004871607	0.063987308	0.682254817	1	1
RMDN3	glycogen synthase kinase 3 beta/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
RMDN3	hek293 cells	0.000465113	0.001481189	0.05	0.684648414	1	0
RMDN3	homeostasis/physiology	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
RMDN3	mitochondria/metabolism	0.004675793	0.007521579	0.048587294	0.395836357	2	4
RMDN3	mitochondrial proteins/metabolism	0.000563996	0.001702766	0.007932311	0.36812785	2	1
RMDN3	mutation	0.003528944	0.006899146	0.045742574	0.360232201	2	3
RMDN3	protein tyrosine phosphatases/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
RMDN3	rna-binding protein fus/genetics	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
RMDN3	vesicular transport proteins/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
SIRT1	dopaminergic neurons/metabolism	0.00044227	0.00104339	0.207920792	0.675762622	1	3
SIRT1	mitochondria/metabolism	0.001068022	0.001906538	0.222929936	0.704306703	1	4
SIRT1	neural stem cells/metabolism	1.56E-06	8.51E-06	0.1	0.684648414	1	0
SIRT1	oxidopamine/pharmacology	5.68E-14	1.16E-12	0.033333333	0.684648414	1	0
SIRT1	parkinson disease/metabolism	1.24E-05	4.00E-05	0.158415842	0.675762622	1	3
SIRT1	protein deglycase dj-1/metabolism	0	0	0.016666667	0.684648414	1	0
SIRT1	substantia nigra/metabolism	0.000481808	0.001529592	0.116666667	0.684648414	1	0
SKIL	STIL	0	0	0.006369427	0.704306703	1	4
SKIL	amino acid chloromethyl ketones/pharmacology	0.000553775	0.001021783	0.070063694	0.704306703	1	4
SKIL	antineoplastic agents phytogenic/isolation & purification	0	0	0.006369427	0.704306703	1	4
SKIL	caspase 3/metabolism	0.000475505	0.000885677	0.063694268	0.704306703	1	4
SKIL	caspase 7/metabolism	4.90E-13	2.08E-12	0.012738854	0.704306703	1	4
SKIL	cell line tumor	0.002767672	0.004617795	0.089171975	0.704306703	1	4
SKIL	cell shape/drug effects	6.22E-15	2.92E-14	0.012738854	0.704306703	1	4
SKIL	cytochromes c/metabolism	8.12E-12	3.16E-11	0.01910828	0.704306703	1	4
SKIL	dose-response relationship drug	0.00386251	0.006286294	0.095541401	0.704306703	1	4
SKIL	esophageal neoplasms/metabolism	0	0	0.006369427	0.704306703	1	4
SKIL	leukocytes mononuclear/drug effects	2.84E-12	1.13E-11	0.012738854	0.704306703	1	4
SKIL	phosphatidylserines/metabolism	7.80E-05	0.000163042	0.050955414	0.704306703	1	4
SKIL	plant extracts/isolation & purification	0	0	0.006369427	0.704306703	1	4
SKIL	protein transport	1.42E-14	6.57E-14	0.01910828	0.704306703	1	4
SLC25A4	SOD1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SLC25A4	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
SLC25A4	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SLC25A4	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SLC25A4	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SLC25A4	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
SLC25A4	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
SLC25A4	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
SLC25A4	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SLC6A3	antioxidants/pharmacology	1.58E-05	3.59E-05	0.038216561	0.704306703	1	4
SLC6A3	caspase inhibitors/pharmacology	8.02E-07	2.13E-06	0.038216561	0.704306703	1	4
SLC6A3	cytoprotection	0	0	0.006369427	0.704306703	1	4
SLC6A3	dopamine plasma membrane transport proteins/metabolism	0	0	0.006369427	0.704306703	1	4
SLC6A3	dopaminergic neurons/drug effects	9.99E-16	4.87E-15	0.012738854	0.704306703	1	4
SLC6A3	dose-response relationship drug	0.00386251	0.006286294	0.095541401	0.704306703	1	4
SLC6A3	energy metabolism/drug effects	0	0	0.012738854	0.704306703	1	4
SLC6A3	genes reporter	6.22E-15	2.92E-14	0.012738854	0.704306703	1	4
SLC6A3	iron chelating agents/pharmacology	0	0	0.006369427	0.704306703	1	4
SLC6A3	oxidative stress/drug effects	0.000124192	0.000249787	0.057324841	0.704306703	1	4
SLC6A3	protein kinase inhibitors/pharmacology	2.58E-13	1.11E-12	0.012738854	0.704306703	1	4
SLC6A3	uncoupling agents/pharmacology	9.99E-16	4.87E-15	0.012738854	0.704306703	1	4
SMARCA1	SMARCA2	0	0	0.006369427	0.704306703	1	4
SMARCA1	SMARCA4	0	0	0.006369427	0.704306703	1	4
SMARCA1	SOX3	0	0	0.006369427	0.704306703	1	4
SMARCA1	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
SMARCA1	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA1	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA1	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA1	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
SMARCA1	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
SMARCA1	heterozygote	0	0	0.012738854	0.704306703	1	4
SMARCA1	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
SMARCA1	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA1	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
SMARCA1	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
SMARCA2	SMARCA4	0	0	0.006369427	0.704306703	1	4
SMARCA2	SOX3	0	0	0.006369427	0.704306703	1	4
SMARCA2	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
SMARCA2	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA2	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA2	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA2	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
SMARCA2	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
SMARCA2	heterozygote	0	0	0.012738854	0.704306703	1	4
SMARCA2	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
SMARCA2	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA2	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
SMARCA2	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
SMARCA4	SOX3	0	0	0.006369427	0.704306703	1	4
SMARCA4	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
SMARCA4	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA4	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA4	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA4	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
SMARCA4	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
SMARCA4	heterozygote	0	0	0.012738854	0.704306703	1	4
SMARCA4	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
SMARCA4	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
SMARCA4	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
SMARCA4	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
SNCA	alpha-synuclein/antagonists & inhibitors	0.00241481	0.004061118	0.114649682	0.704306703	1	4
SNCA	alpha-synuclein/genetics	0.000155979	0.000559964	1.49E-05	5.14E-05	9	0
SNCA	alpha-synuclein/metabolism	0.003304476	0.008316752	0.0103783	0.05875666	4	1
SNCA	antigen presentation	0.005146796	0.009328781	0.148514851	0.675762622	1	3
SNCA	astrocytes/immunology	0.005146796	0.009328781	0.148514851	0.675762622	1	3
SNCA	brain/drug effects	0.003768457	0.007206893	0.148514851	0.675762622	1	3
SNCA	brain/metabolism	0.004030067	0.009852302	0.241935484	0.682254817	1	1
SNCA	carbonyl cyanide m-chlorophenyl hydrazone/pharmacology	0.003768457	0.007206893	0.148514851	0.675762622	1	3
SNCA	cations divalent/metabolism	0.004145772	0.006722712	0.114649682	0.704306703	1	4
SNCA	cell differentiation	0.000947973	0.002134311	0.064962185	0.155527348	3	3
SNCA	cell differentiation/genetics	0.000909324	0.001632726	0.033707577	0.069401824	4	4
SNCA	cell respiration	0.000306214	0.000739214	0.020792079	0.360232201	2	3
SNCA	cells cultured	0.000104751	0.000286729	0.005913544	0.004574958	6	3
SNCA	cellular senescence/drug effects	0.00241481	0.004061118	0.114649682	0.704306703	1	4
SNCA	crispr-cas systems	0.004030067	0.009852302	0.241935484	0.682254817	1	1
SNCA	curcumin/pharmacology	0.000829396	0.001499887	0.114649682	0.704306703	1	4
SNCA	dopaminergic neurons/metabolism	0.001448531	0.003139347	0.056124034	0.004574958	6	3
SNCA	dynamins/metabolism	0.000632031	0.0014604	0.148514851	0.675762622	1	3
SNCA	embryonic stem cells/metabolism	5.41E-05	0.000162224	0.148514851	0.675762622	1	3
SNCA	endopeptidase clp/antagonists & inhibitors	0.003207478	0.005283806	0.114649682	0.704306703	1	4
SNCA	endoplasmic reticulum stress/genetics	0.000632031	0.0014604	0.148514851	0.675762622	1	3
SNCA	gain of function mutation	0.003207478	0.005283806	0.114649682	0.704306703	1	4
SNCA	gene duplication	0.00241481	0.004061118	0.114649682	0.704306703	1	4
SNCA	gene products tat/chemistry	3.58E-05	7.88E-05	0.114649682	0.704306703	1	4
SNCA	genome human	0.00241481	0.004061118	0.114649682	0.704306703	1	4
SNCA	glucose/deficiency	0.00241481	0.004061118	0.114649682	0.704306703	1	4
SNCA	glucosylceramidase/genetics	0.00241481	0.004061118	0.114649682	0.704306703	1	4
SNCA	hla-drb1 chains/chemistry	0.005146796	0.009328781	0.148514851	0.675762622	1	3
SNCA	homeostasis/physiology	0.004145772	0.006722712	0.114649682	0.704306703	1	4
SNCA	hsp70 heat-shock proteins/biosynthesis	3.58E-05	7.88E-05	0.114649682	0.704306703	1	4
SNCA	induced pluripotent stem cells/metabolism	7.10E-07	2.96E-06	0.001724634	4.33E-05	9	3
SNCA	inflammation mediators/metabolism	0.005146796	0.009328781	0.148514851	0.675762622	1	3
SNCA	lewy bodies/metabolism	0.003768457	0.007206893	0.148514851	0.675762622	1	3
SNCA	lipid metabolism/genetics	0.000632031	0.0014604	0.148514851	0.675762622	1	3
SNCA	mitochondria/genetics	0.001498257	0.003232261	0.128510873	0.155527348	3	3
SNCA	mitochondria/metabolism	0.002624379	0.00439912	0.072166145	0.001629855	7	4
SNCA	mitochondrial proton-translocating atpases/metabolism	5.41E-05	0.000162224	0.148514851	0.675762622	1	3
SNCA	mitochondrial turnover/drug effects	0.003768457	0.007206893	0.148514851	0.675762622	1	3
SNCA	mitophagy/genetics	0.005770536	0.00915971	0.100983258	0.395836357	2	4
SNCA	mutation	0.003115174	0.006234353	0.070200339	0.004574958	6	3
SNCA	neurons/metabolism	6.31E-05	0.000133349	0.033707577	0.069401824	4	4
SNCA	neuroprotective agents/chemistry	3.58E-05	7.88E-05	0.114649682	0.704306703	1	4
SNCA	nf-e2-related factor 2/metabolism	0.003768457	0.007206893	0.148514851	0.675762622	1	3
SNCA	parkinson disease/genetics	5.93E-07	2.48E-06	0.000747768	7.54E-06	10	3
SNCA	pc12 cells	0.001936994	0.003336209	0.065022588	0.395836357	2	4
SNCA	postmortem changes	0.003768457	0.007206893	0.148514851	0.675762622	1	3
SNCA	recombinant fusion proteins/metabolism	3.58E-05	7.88E-05	0.114649682	0.704306703	1	4
SNCA	recombinant proteins/metabolism	0.003207478	0.005283806	0.114649682	0.704306703	1	4
SNCA	rna small interfering/genetics	0.000476721	0.001119575	0.020792079	0.360232201	2	3
SNCA	substantia nigra/metabolism	0.003722104	0.007138291	0.064962185	0.155527348	3	3
SNCA	superoxide dismutase/metabolism	0.003207478	0.005283806	0.114649682	0.704306703	1	4
SOD1	SOD2	0.000338715	0.000811561	0.01980198	0.675762622	1	3
SOD1	SQSTM1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SOD1	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SOD1	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SOD1	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
SOD1	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
SOD1	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
SOD1	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SOD2	SQSTM1	0.000338715	0.000811561	0.01980198	0.675762622	1	3
SOD2	UTRN	0.000338715	0.000811561	0.01980198	0.675762622	1	3
SOD2	VDAC1	0.000338715	0.000811561	0.01980198	0.675762622	1	3
SOD2	amyotrophic lateral sclerosis/genetics	0.003460454	0.005675104	0.062877674	0.704306703	1	4
SOD2	cell respiration	0.000141618	0.000512002	0.033333333	0.684648414	1	0
SOD2	dna-binding proteins/genetics	0.003908871	0.006350131	0.075208231	0.704306703	1	4
SOD2	endopeptidase clp/antagonists & inhibitors	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOD2	gain of function mutation	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOD2	genes reporter	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOD2	mitochondria/enzymology	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOD2	mutation missense	0.000980754	0.002910234	0.05	0.684648414	1	0
SOD2	neuromuscular junction/genetics	0.000338715	0.000811561	0.01980198	0.675762622	1	3
SOD2	oxidative stress	0.004016132	0.008884455	0.071428571	0.6737233	1	2
SOD2	reactive oxygen species	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOD2	recombinant proteins/metabolism	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOD2	rna interference	0.000177032	0.000621894	0.033333333	0.684648414	1	0
SOD2	rna small interfering/genetics	0.000218723	0.000750299	0.033333333	0.684648414	1	0
SOD2	superoxide dismutase/metabolism	1.82E-07	1.10E-06	0.016666667	0.684648414	1	0
SOX11	SOX12	0	0	0.006369427	0.704306703	1	4
SOX11	SOX4	0	0	0.006369427	0.704306703	1	4
SOX11	abnormalities multiple/genetics	0	0	0.006369427	0.704306703	1	4
SOX11	cell differentiation	1.41E-05	3.22E-05	0.076433121	0.704306703	1	4
SOX11	cell proliferation	0	0	0.01910828	0.704306703	1	4
SOX11	crispr-cas systems	0	0	0.012738854	0.704306703	1	4
SOX11	face/abnormalities	0	0	0.006369427	0.704306703	1	4
SOX11	hand deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SOX11	haploinsufficiency	0	0	0.006369427	0.704306703	1	4
SOX11	human embryonic stem cells/metabolism	2.30E-05	5.14E-05	0.063694268	0.704306703	1	4
SOX11	micrognathism/genetics	0	0	0.006369427	0.704306703	1	4
SOX11	neck/abnormalities	0	0	0.006369427	0.704306703	1	4
SOX11	neural stem cells	0	0	0.012738854	0.704306703	1	4
SOX11	soxc transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
SOX12	SOX4	0	0	0.006369427	0.704306703	1	4
SOX12	abnormalities multiple/genetics	0	0	0.006369427	0.704306703	1	4
SOX12	cell differentiation	1.41E-05	3.22E-05	0.076433121	0.704306703	1	4
SOX12	cell proliferation	0	0	0.01910828	0.704306703	1	4
SOX12	crispr-cas systems	0	0	0.012738854	0.704306703	1	4
SOX12	face/abnormalities	0	0	0.006369427	0.704306703	1	4
SOX12	hand deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SOX12	haploinsufficiency	0	0	0.006369427	0.704306703	1	4
SOX12	human embryonic stem cells/metabolism	2.30E-05	5.14E-05	0.063694268	0.704306703	1	4
SOX12	micrognathism/genetics	0	0	0.006369427	0.704306703	1	4
SOX12	neck/abnormalities	0	0	0.006369427	0.704306703	1	4
SOX12	neural stem cells	0	0	0.012738854	0.704306703	1	4
SOX12	soxc transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
SOX3	cell differentiation/genetics	0.000706707	0.001289602	0.076433121	0.704306703	1	4
SOX3	chromatin/genetics	0	0	0.006369427	0.704306703	1	4
SOX3	dna helicases/genetics	0	0	0.006369427	0.704306703	1	4
SOX3	foot deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SOX3	fos-related antigen-2/biosynthesis	0	0	0.006369427	0.704306703	1	4
SOX3	hek293 cells	5.37E-09	1.73E-08	0.025477707	0.704306703	1	4
SOX3	heterozygote	0	0	0.012738854	0.704306703	1	4
SOX3	human embryonic stem cells/metabolism	0.000267552	0.000516202	0.063694268	0.704306703	1	4
SOX3	hypotrichosis/genetics	0	0	0.006369427	0.704306703	1	4
SOX3	mutation missense	2.67E-05	5.94E-05	0.038216561	0.704306703	1	4
SOX3	neural stem cells/metabolism	1.65E-07	4.74E-07	0.044585987	0.704306703	1	4
SOX4	abnormalities multiple/genetics	0	0	0.006369427	0.704306703	1	4
SOX4	cell differentiation	1.41E-05	3.22E-05	0.076433121	0.704306703	1	4
SOX4	cell proliferation	0	0	0.01910828	0.704306703	1	4
SOX4	crispr-cas systems	0	0	0.012738854	0.704306703	1	4
SOX4	face/abnormalities	0	0	0.006369427	0.704306703	1	4
SOX4	hand deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
SOX4	haploinsufficiency	0	0	0.006369427	0.704306703	1	4
SOX4	human embryonic stem cells/metabolism	2.30E-05	5.14E-05	0.063694268	0.704306703	1	4
SOX4	micrognathism/genetics	0	0	0.006369427	0.704306703	1	4
SOX4	neck/abnormalities	0	0	0.006369427	0.704306703	1	4
SOX4	neural stem cells	0	0	0.012738854	0.704306703	1	4
SOX4	soxc transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
SQSTM1	UTRN	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SQSTM1	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
SQSTM1	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
SQSTM1	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
SQSTM1	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
SQSTM1	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
STAT5A	cell line	0.006017887	0.009499708	0.229299363	0.704306703	1	4
STAT5A	crispr-cas systems/genetics	0	0	0.01910828	0.704306703	1	4
STAT5A	homologous recombination	0	0	0.006369427	0.704306703	1	4
STAT5A	homozygote	0	0	0.012738854	0.704306703	1	4
STAT5A	human embryonic stem cells/metabolism	1.83E-07	5.22E-07	0.063694268	0.704306703	1	4
STAT5A	kruppel-like transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
STAT5A	mutation/genetics	8.93E-06	2.09E-05	0.089171975	0.704306703	1	4
STAT5A	oncostatin m receptor beta subunit/genetics	0	0	0.006369427	0.704306703	1	4
STIL	amino acid chloromethyl ketones/pharmacology	0.000553775	0.001021783	0.070063694	0.704306703	1	4
STIL	antineoplastic agents phytogenic/isolation & purification	0	0	0.006369427	0.704306703	1	4
STIL	caspase 3/metabolism	0.000475505	0.000885677	0.063694268	0.704306703	1	4
STIL	caspase 7/metabolism	4.90E-13	2.08E-12	0.012738854	0.704306703	1	4
STIL	cell line tumor	0.002767672	0.004617795	0.089171975	0.704306703	1	4
STIL	cell shape/drug effects	6.22E-15	2.92E-14	0.012738854	0.704306703	1	4
STIL	cytochromes c/metabolism	8.12E-12	3.16E-11	0.01910828	0.704306703	1	4
STIL	dose-response relationship drug	0.00386251	0.006286294	0.095541401	0.704306703	1	4
STIL	esophageal neoplasms/metabolism	0	0	0.006369427	0.704306703	1	4
STIL	leukocytes mononuclear/drug effects	2.84E-12	1.13E-11	0.012738854	0.704306703	1	4
STIL	phosphatidylserines/metabolism	7.80E-05	0.000163042	0.050955414	0.704306703	1	4
STIL	plant extracts/isolation & purification	0	0	0.006369427	0.704306703	1	4
STIL	protein transport	1.42E-14	6.57E-14	0.01910828	0.704306703	1	4
STOML2	blood proteins/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
STOML2	cell line tumor	1.11E-05	5.18E-05	0.05	0.684648414	1	0
STOML2	dopaminergic neurons/metabolism	0.004641712	0.008570101	0.207920792	0.675762622	1	3
STOML2	drosophila proteins/metabolism	1.24E-11	1.87E-10	0.033333333	0.684648414	1	0
STOML2	electron transport complex i/metabolism	1.11E-16	2.61E-15	0.016666667	0.684648414	1	0
STOML2	induced pluripotent stem cells/metabolism	0.00083398	0.00150223	0.165605096	0.704306703	1	4
STOML2	mutation	0.004413946	0.007122054	0.210191083	0.704306703	1	4
STOML2	parkinson disease/genetics	0.003263923	0.005366331	0.197452229	0.704306703	1	4
STOML2	substantia nigra/metabolism	0.003930343	0.009647206	0.112903226	0.682254817	1	1
STOML2	ubiquitin-protein ligases/metabolism	0.000165081	0.000438006	0.108910891	0.675762622	1	3
TARDBP	amyotrophic lateral sclerosis/genetics	0	0	0.001242236	0.357776018	2	2
TARDBP	annexin a5/metabolism	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	atp binding cassette transporter subfamily b/genetics	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	bismuth/pharmacology	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	caspase inhibitors	2.24E-06	8.38E-06	0.078019802	0.675762622	1	3
TARDBP	caspases/drug effects	3.03E-05	9.33E-05	0.115271527	0.675762622	1	3
TARDBP	cell death/genetics	2.89E-14	4.38E-13	0.028571429	0.6737233	1	2
TARDBP	cell differentiation/drug effects	9.24E-07	3.79E-06	0.078019802	0.675762622	1	3
TARDBP	cell proliferation/drug effects	0.00286331	0.005784481	0.115271527	0.675762622	1	3
TARDBP	cell survival/drug effects	0.000201768	0.000507497	0.038832455	0.360232201	2	3
TARDBP	cytoplasm/metabolism	2.89E-14	4.38E-13	0.028571429	0.6737233	1	2
TARDBP	dna neoplasm/drug effects	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	dna-binding proteins/genetics	2.95E-06	1.30E-05	0.08447205	0.6737233	1	2
TARDBP	dna-binding proteins/metabolism	1.84E-07	9.48E-07	0.056728778	0.6737233	1	2
TARDBP	gene expression regulation neoplastic/drug effects	5.64E-07	2.37E-06	0.078019802	0.675762622	1	3
TARDBP	genes mdr/drug effects	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	hl-60 cells	7.67E-05	0.000224774	0.115271527	0.675762622	1	3
TARDBP	hl-60 cells/drug effects	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	kaempferols/pharmacology	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	leukemia promyelocytic acute/drug therapy	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	mitochondria/pathology	6.27E-09	3.79E-08	0.056728778	0.6737233	1	2
TARDBP	mitochondrial proteins/genetics	0.001267217	0.003235419	0.111801242	0.6737233	1	2
TARDBP	motor neurons/metabolism	0	0	0.001242236	0.357776018	2	2
TARDBP	multidrug resistance-associated proteins/genetics	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	muscles/innervation	2.89E-14	4.38E-13	0.028571429	0.6737233	1	2
TARDBP	mutation missense	0.001746616	0.004282317	0.111801242	0.6737233	1	2
TARDBP	nerve degeneration/genetics	0.003908871	0.006350131	0.2063275	0.704306703	1	4
TARDBP	neuromuscular junction/metabolism	0	0	0.000414079	0.357776018	2	2
TARDBP	organometallic compounds/pharmacology	4.44E-16	4.11E-15	0.03960396	0.675762622	1	3
TARDBP	protein transport	2.89E-14	4.38E-13	0.028571429	0.6737233	1	2
TARDBP	repressor proteins/genetics	0.000136406	0.000273996	0.122551991	0.704306703	1	4
TARDBP	rna long noncoding/genetics	6.76E-08	1.99E-07	0.062877674	0.704306703	1	4
TFAM	TNF	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TFAM	acyl-coa dehydrogenases/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	dopaminergic neurons/ultrastructure	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	electron transport complex i/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	frontal lobe/pathology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	gene expression regulation/drug effects	1.59E-05	7.14E-05	0.033333333	0.684648414	1	0
TFAM	micrornas/genetics	7.54E-06	3.71E-05	0.033333333	0.684648414	1	0
TFAM	mitochondrial proteins/genetics	0.000440857	0.001422781	0.05	0.684648414	1	0
TFAM	mitochondrial turnover/physiology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	neural stem cells	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	nuclear respiratory factor 1/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	parkinson disease/pathology	0.000192697	0.000505493	0.069306931	0.675762622	1	3
TFAM	rotenone/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TFAM	tumor necrosis factor-alpha/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
TNF	acyl-coa dehydrogenases/genetics	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	antigen presentation	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNF	antigens cd/genetics	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
TNF	apoptosis/genetics	0.000637846	0.001472587	0.078019802	0.675762622	1	3
TNF	astrocytes/immunology	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNF	camptothecin/pharmacology	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
TNF	cell membrane/metabolism	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNF	cell respiration	0.00244146	0.005760149	0.056728778	0.6737233	1	2
TNF	chromones/pharmacology	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
TNF	cytosol/drug effects	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
TNF	dopaminergic neurons/ultrastructure	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	drug resistance neoplasm	0.000637846	0.001472587	0.078019802	0.675762622	1	3
TNF	electron transport complex i/genetics	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	frontal lobe/pathology	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	gene expression regulation neoplastic/drug effects	6.60E-05	0.000196475	0.078019802	0.675762622	1	3
TNF	gene expression regulation/drug effects	0.001992898	0.005476452	0.066101695	0.684648414	1	0
TNF	gene expression/drug effects	0.000560688	0.001034311	0.075208231	0.704306703	1	4
TNF	hepatocytes/drug effects	0.005974197	0.009455463	0.111006622	0.704306703	1	4
TNF	hl-60 cells	0.001688313	0.003595378	0.115271527	0.675762622	1	3
TNF	hla-drb1 chains/chemistry	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNF	inflammation mediators/metabolism	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNF	membrane glycoproteins/pharmacokinetics	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
TNF	micrornas/genetics	0.001321777	0.003758517	0.066101695	0.684648414	1	0
TNF	mitochondrial turnover/physiology	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	morpholines/pharmacology	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
TNF	neural stem cells	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	nf-kappa b/metabolism	0.000272555	0.000669679	0.078019802	0.675762622	1	3
TNF	nuclear respiratory factor 1/genetics	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	parkinson disease/pathology	0.002422409	0.00647824	0.011864407	0.371068466	2	0
TNF	phosphoinositide-3 kinase inhibitors	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
TNF	receptors tumor necrosis factor type i	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
TNF	rna messenger/analysis	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
TNF	rna small interfering/metabolism	0.000212939	0.000529772	0.078019802	0.675762622	1	3
TNF	rotenone/pharmacology	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNF	specific pathogen-free organisms	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
TNF	topoisomerase inhibitors	5.42E-06	1.30E-05	0.038216561	0.704306703	1	4
TNF	tumor necrosis factor-alpha/metabolism	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNF	tumor necrosis factor-alpha/pharmacokinetics	2.97E-07	1.28E-06	0.03960396	0.675762622	1	3
TNF	tumor necrosis factor-alpha/pharmacology	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
TNS1	apoptosis/drug effects	0.003362639	0.008691422	0.066666667	0.684648414	1	0
TNS1	cell survival	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
TNS1	hydrogen peroxide/pharmacology	2.40E-05	0.000102874	0.033333333	0.684648414	1	0
TNS1	membrane potential mitochondrial	8.36E-05	0.000322646	0.05	0.684648414	1	0
TNS1	mesenchymal stem cells/metabolism	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
TNS1	oxidative stress	0.003619594	0.009273508	0.083333333	0.684648414	1	0
TNS1	oxidopamine	2.40E-07	1.42E-06	0.033333333	0.684648414	1	0
TNS1	parkinson disease/pathology	7.35E-05	0.000217772	0.069306931	0.675762622	1	3
TNS1	phenotype	0.000897763	0.00202545	0.108910891	0.675762622	1	3
TNS1	ubiquitin-protein ligases/metabolism	0.001205048	0.002644787	0.108910891	0.675762622	1	3
TNS1	wharton jelly/cytology	5.11E-10	5.58E-09	0.016666667	0.684648414	1	0
UTRN	VDAC1	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
UTRN	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
UTRN	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
UTRN	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
UTRN	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
VAPB	adenosine triphosphate/metabolism	0.001173863	0.003382612	0.05	0.684648414	1	0
VAPB	amyotrophic lateral sclerosis/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
VAPB	calcium/metabolism	0.002154272	0.005876463	0.05	0.684648414	1	0
VAPB	cations divalent/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
VAPB	cell line tumor	0.000762885	0.002317561	0.05	0.684648414	1	0
VAPB	endoplasmic reticulum/metabolism	0.000133262	0.000485659	0.033333333	0.684648414	1	0
VAPB	gene expression	0.001805441	0.004871607	0.063987308	0.682254817	1	1
VAPB	glycogen synthase kinase 3 beta/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
VAPB	hek293 cells	0.000465113	0.001481189	0.05	0.684648414	1	0
VAPB	homeostasis/physiology	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
VAPB	mitochondria/metabolism	0.004675793	0.007521579	0.048587294	0.395836357	2	4
VAPB	mitochondrial proteins/metabolism	0.000563996	0.001702766	0.007932311	0.36812785	2	1
VAPB	mutation	0.003528944	0.006899146	0.045742574	0.360232201	2	3
VAPB	protein tyrosine phosphatases/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
VAPB	rna-binding protein fus/genetics	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
VAPB	vesicular transport proteins/metabolism	7.44E-07	4.16E-06	0.016666667	0.684648414	1	0
VDAC1	amyotrophic lateral sclerosis/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
VDAC1	dna-binding proteins/genetics	0.002534175	0.005164561	0.04950495	0.675762622	1	3
VDAC1	mutation missense	0.002041425	0.003496484	0.038216561	0.704306703	1	4
VDAC1	neuromuscular junction/genetics	7.91E-06	2.59E-05	0.00990099	0.675762622	1	3
WDTC1	adenosine triphosphate/antagonists & inhibitors	2.25E-09	7.60E-09	0.037971583	0.704306703	1	4
WDTC1	annexin a5/metabolism	2.25E-09	7.60E-09	0.037971583	0.704306703	1	4
WDTC1	benzamides/pharmacology	2.11E-07	6.01E-07	0.037971583	0.704306703	1	4
WDTC1	burkitt lymphoma	9.55E-15	4.46E-14	0.01910828	0.704306703	1	4
WDTC1	calcimycin/pharmacology	9.55E-15	4.46E-14	0.01910828	0.704306703	1	4
WDTC1	caspase inhibitors/pharmacology	0.00222304	0.003765957	0.111006622	0.704306703	1	4
WDTC1	cell differentiation/drug effects	7.60E-06	1.79E-05	0.056591487	0.704306703	1	4
WDTC1	etoposide/pharmacology	0.000900018	0.001616189	0.074969575	0.704306703	1	4
WDTC1	hydrogen peroxide/pharmacology	0.000321909	0.00061393	0.074969575	0.704306703	1	4
WDTC1	jurkat cells	0	0	0.000731773	0.395836357	2	4
WDTC1	mitochondria/enzymology	7.60E-06	1.79E-05	0.056591487	0.704306703	1	4
WDTC1	neoplasm proteins/genetics	2.14E-11	8.20E-11	0.037971583	0.704306703	1	4
WDTC1	oligomycins/pharmacology	9.55E-15	4.46E-14	0.01910828	0.704306703	1	4
WDTC1	oxidative stress	0.006239108	0.009818666	0.146095368	0.704306703	1	4
WDTC1	quinazolinones	9.55E-15	4.46E-14	0.01910828	0.704306703	1	4
ZMYM2	cell proliferation	0	0	0.01910828	0.704306703	1	4
ZMYM2	dna-binding proteins/genetics	1.11E-16	5.69E-16	0.038216561	0.704306703	1	4
ZMYM2	human embryonic stem cells	0	0	0.025477707	0.704306703	1	4
ZMYM2	mutation	0.000151269	0.000302915	0.210191083	0.704306703	1	4
ZMYM2	neoplasm proteins/genetics	0	0	0.012738854	0.704306703	1	4
ZMYM2	transcription factors/genetics	0	0	0.038216561	0.704306703	1	4
abnormalities multiple/genetics	cell differentiation	1.41E-05	3.22E-05	0.076433121	0.704306703	1	4
abnormalities multiple/genetics	cell proliferation	0	0	0.01910828	0.704306703	1	4
abnormalities multiple/genetics	crispr-cas systems	0	0	0.012738854	0.704306703	1	4
abnormalities multiple/genetics	face/abnormalities	0	0	0.006369427	0.704306703	1	4
abnormalities multiple/genetics	hand deformities congenital/genetics	0	0	0.006369427	0.704306703	1	4
abnormalities multiple/genetics	haploinsufficiency	0	0	0.006369427	0.704306703	1	4
abnormalities multiple/genetics	human embryonic stem cells/metabolism	2.30E-05	5.14E-05	0.063694268	0.704306703	1	4
abnormalities multiple/genetics	micrognathism/genetics	0	0	0.006369427	0.704306703	1	4
abnormalities multiple/genetics	neck/abnormalities	0	0	0.006369427	0.704306703	1	4
abnormalities multiple/genetics	neural stem cells	0	0	0.012738854	0.704306703	1	4
abnormalities multiple/genetics	soxc transcription factors/genetics	0	0	0.006369427	0.704306703	1	4
acetylcysteine/pharmacology	antioxidants/pharmacology	2.38E-06	6.11E-06	0.003611449	0.395836357	2	4
acetylcysteine/pharmacology	bcl-2-associated x protein/metabolism	4.23E-05	9.18E-05	0.037971583	0.704306703	1	4
acetylcysteine/pharmacology	benzamides/pharmacology	0	0	0.00990099	0.675762622	1	3
acetylcysteine/pharmacology	drug interactions	0	0	0.00990099	0.675762622	1	3
acetylcysteine/pharmacology	hydrogen peroxide/pharmacology	1.29E-07	5.83E-07	0.02970297	0.675762622	1	3
acetylcysteine/pharmacology	necrosis/chemically induced	0	0	0.00990099	0.675762622	1	3
acetylcysteine/pharmacology	oxidative stress	5.11E-05	0.000153604	0.059405941	0.675762622	1	3
acetylcysteine/pharmacology	proto-oncogene proteins c-bcl-2/metabolism	5.95E-09	3.18E-08	0.01980198	0.675762622	1	3
acetylcysteine/pharmacology	rna small interfering/metabolism	2.85E-12	2.03E-11	0.01980198	0.675762622	1	3
acetylcysteine/pharmacology	u937 cells	4.71E-13	3.62E-12	0.01980198	0.675762622	1	3
acyl-coa dehydrogenases/genetics	dopaminergic neurons/ultrastructure	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	electron transport complex i/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	frontal lobe/pathology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	gene expression regulation/drug effects	1.59E-05	7.14E-05	0.033333333	0.684648414	1	0
acyl-coa dehydrogenases/genetics	micrornas/genetics	7.54E-06	3.71E-05	0.033333333	0.684648414	1	0
acyl-coa dehydrogenases/genetics	mitochondrial proteins/genetics	0.000440857	0.001422781	0.05	0.684648414	1	0
acyl-coa dehydrogenases/genetics	mitochondrial turnover/physiology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	neural stem cells	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	nuclear respiratory factor 1/genetics	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	parkinson disease/pathology	0.000192697	0.000505493	0.069306931	0.675762622	1	3
acyl-coa dehydrogenases/genetics	rotenone/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyl-coa dehydrogenases/genetics	tumor necrosis factor-alpha/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
acyltransferases/antagonists & inhibitors	apoptosis	0.000495306	0.001156987	0.069306931	0.675762622	1	3
acyltransferases/antagonists & inhibitors	bortezomib	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	cdc2 protein kinase/metabolism	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	cdc25 phosphatases/metabolism	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	cell division	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	cell line tumor	0.004463825	0.008309562	0.089108911	0.675762622	1	3
acyltransferases/antagonists & inhibitors	dose-response relationship drug	0.001186993	0.002609374	0.069306931	0.675762622	1	3
acyltransferases/antagonists & inhibitors	drug resistance neoplasm	3.28E-10	1.95E-09	0.01980198	0.675762622	1	3
acyltransferases/antagonists & inhibitors	g2 phase	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	multiple myeloma/drug therapy	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	necrosis	5.80E-10	3.37E-09	0.01980198	0.675762622	1	3
acyltransferases/antagonists & inhibitors	poly(adp-ribose) polymerases/metabolism	0	0	0.00990099	0.675762622	1	3
acyltransferases/antagonists & inhibitors	proteasome inhibitors	0	0	0.00990099	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	apoptosis	0.005442632	0.009848615	0.134455446	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	apoptosis/physiology	2.24E-06	8.38E-06	0.058811881	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	calcium/metabolism	0.001959502	0.004096833	0.115841584	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	caspases/drug effects	8.50E-07	3.53E-06	0.058811881	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	cervix uteri/cytology	0	0	0.01980198	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	endothelial cells/drug effects	1.37E-08	6.74E-08	0.039405941	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	enzyme inhibitors/pharmacology	1.19E-06	4.87E-06	0.039405941	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	epithelial cells/drug effects	0	0	0.01980198	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	mitogen-activated protein kinase 1/metabolism	4.62E-14	3.86E-13	0.01980198	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	platelet aggregation inhibitors/pharmacology	0	0	0.01980198	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	receptors purinergic p2x7	0	0	0.01980198	0.675762622	1	3
adenosine triphosphate/analogs & derivatives	tumor necrosis factor-alpha/metabolism	2.45E-08	1.18E-07	0.039405941	0.675762622	1	3
adenosine triphosphate/antagonists & inhibitors	amino acid chloromethyl ketones/pharmacology	0.00374191	0.006115922	0.135636126	0.704306703	1	4
adenosine triphosphate/antagonists & inhibitors	apoptosis/drug effects	0.003501777	0.006899146	0.198019802	0.675762622	1	3
adenosine triphosphate/antagonists & inhibitors	cell differentiation/drug effects	1.47E-09	5.04E-09	0.037971583	0.704306703	1	4
adenosine triphosphate/antagonists & inhibitors	cytochrome c group/metabolism	0	0	0.02970297	0.675762622	1	3
adenosine triphosphate/antagonists & inhibitors	jurkat cells	1.03E-08	3.27E-08	0.037971583	0.704306703	1	4
adenosine triphosphate/antagonists & inhibitors	mitochondria/enzymology	0	0	0.01980198	0.675762622	1	3
adenosine triphosphate/antagonists & inhibitors	tumor cells cultured	7.18E-13	5.50E-12	0.02970297	0.675762622	1	3
adenosine triphosphate/biosynthesis	alpha-chlorohydrin/toxicity	0	0	0.00990099	0.675762622	1	3
adenosine triphosphate/biosynthesis	caspases/drug effects	9.77E-13	7.42E-12	0.02970297	0.675762622	1	3
adenosine triphosphate/biosynthesis	cell survival/drug effects	0.000917682	0.002068248	0.089108911	0.675762622	1	3
adenosine triphosphate/biosynthesis	chemosterilants/toxicity	0	0	0.00990099	0.675762622	1	3
adenosine triphosphate/biosynthesis	membrane potential mitochondrial/drug effects	0.000665485	0.001534121	0.079207921	0.675762622	1	3
adenosine triphosphate/biosynthesis	mitochondria/drug effects	0.004714039	0.008676106	0.148514851	0.675762622	1	3
adenosine triphosphate/biosynthesis	reactive oxygen species/metabolism	0.002573922	0.005232841	0.108910891	0.675762622	1	3
adenosine triphosphate/metabolism	amino acid chloromethyl ketones/pharmacology	0.00017017	0.000339638	1.47E-05	1.40E-05	10	4
adenosine triphosphate/metabolism	amyotrophic lateral sclerosis/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	annexin a5/metabolism	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	antigen presentation	0.000261865	0.000890819	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	apoptosis/drug effects	0.004155306	0.00780158	0.000405524	4.33E-05	9	3
adenosine triphosphate/metabolism	astrocytes/immunology	0.000261865	0.000890819	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	bismuth/pharmacology	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	caspase 2/metabolism	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	caspase inhibitors	0.001083273	0.00240612	0.023762376	0.360232201	2	3
adenosine triphosphate/metabolism	caspase inhibitors/pharmacology	0.000511483	0.000950909	0.000431335	0.006469601	6	4
adenosine triphosphate/metabolism	caspases/metabolism	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	cations divalent/metabolism	0.001173863	0.003382612	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	cell membrane/metabolism	0.000261865	0.000890819	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	dna fragmentation/drug effects	0.001095941	0.001949582	0.000111405	0.001629855	7	4
adenosine triphosphate/metabolism	dna neoplasm/drug effects	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	dose-response relationship drug	0.000714462	0.001643548	0.000946875	0.017151793	5	3
adenosine triphosphate/metabolism	endoplasmic reticulum/metabolism	0.002286383	0.005998592	0.015335801	0.36812785	2	1
adenosine triphosphate/metabolism	glycogen synthase kinase 3 beta/metabolism	0.001173863	0.003382612	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	hl-60 cells/drug effects	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	hla-drb1 chains/chemistry	0.000261865	0.000890819	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	homeostasis/physiology	0.001173863	0.003382612	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	inflammation mediators/metabolism	0.000261865	0.000890819	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	metabolome	8.74E-07	4.88E-06	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	neostriatum/drug effects	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	organometallic compounds/pharmacology	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	phosphatidylserines/metabolism	0.003494863	0.005729311	0.000693679	0.001629855	7	4
adenosine triphosphate/metabolism	protein tyrosine phosphatases/metabolism	0.001173863	0.003382612	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	rna messenger/genetics	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	rna-binding protein fus/genetics	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	rotenone	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	t-2 toxin/toxicity	0.002917059	0.00587238	0.158415842	0.675762622	1	3
adenosine triphosphate/metabolism	tumor necrosis factor-alpha/metabolism	0.000261865	0.000890819	0.05	0.684648414	1	0
adenosine triphosphate/metabolism	ursodeoxycholic acid/pharmacology	0.003143795	0.007921694	0.080645161	0.682254817	1	1
adenosine triphosphate/metabolism	vesicular transport proteins/metabolism	0.001173863	0.003382612	0.05	0.684648414	1	0
adipocytes/cytology	dopaminergic neurons/pathology	0	0	0.016666667	0.684648414	1	0
adipocytes/cytology	electron transport complex i/deficiency	0	0	0.016666667	0.684648414	1	0
adipocytes/cytology	mitochondria/pathology	0	0	0.016666667	0.684648414	1	0
adipocytes/cytology	mitochondrial diseases/etiology	0	0	0.016666667	0.684648414	1	0
adipocytes/cytology	oxidopamine	3.77E-15	8.48E-14	0.033333333	0.684648414	1	0
adipocytes/cytology	parkinson disease/complications	1.42E-14	3.09E-13	0.033333333	0.684648414	1	0
adipocytes/cytology	stem cells	0	0	0.016666667	0.684648414	1	0
adp ribose transferases/pharmacology	amides/pharmacology	0	0	0.006369427	0.704306703	1	4
adp ribose transferases/pharmacology	botulinum toxins/pharmacology	0	0	0.006369427	0.704306703	1	4
adp ribose transferases/pharmacology	caspase 3/metabolism	0.000475505	0.000885677	0.063694268	0.704306703	1	4
adp ribose transferases/pharmacology	myocytes cardiac/drug effects	0	0	0.006369427	0.704306703	1	4
adp ribose transferases/pharmacology	phosphatidylserines/metabolism	7.80E-05	0.000163042	0.050955414	0.704306703	1	4
adp ribose transferases/pharmacology	phospholipid transfer proteins/metabolism	0	0	0.006369427	0.704306703	1	4
adp ribose transferases/pharmacology	pyridines/pharmacology	0	0	0.006369427	0.704306703	1	4
adp ribose transferases/pharmacology	rho gtp-binding proteins/antagonists & inhibitors	0	0	0.012738854	0.704306703	1	4
adp ribose transferases/pharmacology	rho-associated kinases/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
aging/genetics	biological transport active/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	brain/metabolism	0.000203814	0.000620316	0.057142857	0.6737233	1	2
aging/genetics	cell survival/genetics	6.28E-05	0.000211523	0.042857143	0.6737233	1	2
aging/genetics	cholesterol/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	drosophila proteins/genetics	7.58E-05	0.000223325	0.079207921	0.675762622	1	3
aging/genetics	filipin/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	gene expression regulation developmental/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	genes lethal/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	inclusion bodies/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	intracellular membranes/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	mutation/genetics	0.00447086	0.008309562	0.108910891	0.675762622	1	3
aging/genetics	nerve degeneration/genetics	3.31E-05	0.000101416	0.069306931	0.675762622	1	3
aging/genetics	niemann-pick diseases/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	organelles/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	photoreceptor cells invertebrate/metabolism	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/genetics	retinal diseases/genetics	2.62E-09	1.61E-08	0.014285714	0.6737233	1	2
aging/pathology	biomarkers/metabolism	6.30E-12	9.61E-11	0.033333333	0.684648414	1	0
aging/pathology	cellular reprogramming	5.28E-11	7.24E-10	0.033333333	0.684648414	1	0
aging/pathology	cellular senescence	0	0	0.016666667	0.684648414	1	0
aging/pathology	dopaminergic neurons/metabolism	0.001796759	0.003805498	0.207920792	0.675762622	1	3
aging/pathology	fibroblasts/metabolism	1.34E-10	1.76E-09	0.033333333	0.684648414	1	0
aging/pathology	induced pluripotent stem cells/metabolism	0.00286331	0.005784481	0.247524752	0.675762622	1	3
aging/pathology	mesencephalon/pathology	0	0	0.016666667	0.684648414	1	0
aging/pathology	parkinson disease/pathology	0.002399166	0.006420281	0.116666667	0.684648414	1	0
aging/pathology	phenotype	0.00279892	0.007359989	0.133333333	0.684648414	1	0
aging/pathology	protein precursors/metabolism	0	0	0.016666667	0.684648414	1	0
alleles	amyotrophic lateral sclerosis/genetics	0.002624163	0.005322074	0.142634263	0.675762622	1	3
alleles	apoptosis/physiology	1.31E-05	4.24E-05	0.087332733	0.675762622	1	3
alleles	axonal transport	0.000211697	0.000732962	0.098305085	0.684648414	1	0
alleles	cells cultured	0.000223078	0.0007646	0.025423729	0.371068466	2	0
alleles	crispr-cas systems	0	0	0.033333333	0.684648414	1	0
alleles	dna-binding proteins/genetics	0.001852665	0.003885391	0.142634263	0.675762622	1	3
alleles	dopaminergic neurons/cytology	0.002455866	0.005074432	0.169426943	0.675762622	1	3
alleles	exons	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
alleles	gene expression	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
alleles	genetic variation	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
alleles	haplotypes	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
alleles	hsp70 heat-shock proteins/metabolism	9.66E-14	7.80E-13	0.02970297	0.675762622	1	3
alleles	induced pluripotent stem cells/cytology	0.002302941	0.006219765	0.051412429	0.371068466	2	0
alleles	locomotion/genetics	9.66E-14	7.80E-13	0.02970297	0.675762622	1	3
alleles	mutation missense/genetics	9.66E-14	7.80E-13	0.02970297	0.675762622	1	3
alleles	neuromuscular junction/cytology	9.66E-14	7.80E-13	0.02970297	0.675762622	1	3
alleles	neurons/metabolism	0.003196263	0.005267384	0.213478529	0.704306703	1	4
alleles	parkinson disease/genetics	0.001072253	0.001913283	0.099706026	0.395836357	2	4
alleles	proteasome endopeptidase complex/metabolism	9.66E-14	7.80E-13	0.02970297	0.675762622	1	3
alleles	protein isoforms	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
alleles	rna interference	0.000103898	0.000284609	0.087332733	0.675762622	1	3
alleles	tau proteins/genetics	2.87E-09	2.95E-08	0.033333333	0.684648414	1	0
alpha-chlorohydrin/toxicity	caspases/drug effects	9.77E-13	7.42E-12	0.02970297	0.675762622	1	3
alpha-chlorohydrin/toxicity	cell survival/drug effects	0.000917682	0.002068248	0.089108911	0.675762622	1	3
alpha-chlorohydrin/toxicity	chemosterilants/toxicity	0	0	0.00990099	0.675762622	1	3
alpha-chlorohydrin/toxicity	membrane potential mitochondrial/drug effects	0.000665485	0.001534121	0.079207921	0.675762622	1	3
alpha-chlorohydrin/toxicity	mitochondria/drug effects	0.004714039	0.008676106	0.148514851	0.675762622	1	3
alpha-chlorohydrin/toxicity	reactive oxygen species/metabolism	0.002573922	0.005232841	0.108910891	0.675762622	1	3
alpha-synuclein/antagonists & inhibitors	cell differentiation	2.63E-05	8.13E-05	0.069306931	0.675762622	1	3
alpha-synuclein/antagonists & inhibitors	cell survival/drug effects	0.000114738	0.000430424	0.033333333	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	cellular senescence/drug effects	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	gene duplication	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	gene expression regulation	0.000600976	0.001874439	0.05	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	glucose/deficiency	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	hydrogen peroxide/pharmacology	7.08E-05	0.000277178	0.033333333	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	membrane potential mitochondrial/drug effects	0.002834813	0.006457452	0.057142857	0.6737233	1	2
alpha-synuclein/antagonists & inhibitors	neural stem cells/drug effects	0.001654299	0.00462051	0.05	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	rna small interfering/genetics	0.000143335	0.000515931	0.033333333	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	staurosporine/pharmacology	3.53E-08	2.37E-07	0.016666667	0.684648414	1	0
alpha-synuclein/antagonists & inhibitors	substantia nigra/metabolism	0.000140559	0.000374859	0.069306931	0.675762622	1	3
alpha-synuclein/chemistry	axonal transport	2.23E-08	1.97E-07	0.05	0.684648414	1	0
alpha-synuclein/chemistry	homeostasis	0	0	0.016666667	0.684648414	1	0
alpha-synuclein/chemistry	human embryonic stem cells/metabolism	4.19E-13	8.01E-12	0.033333333	0.684648414	1	0
alpha-synuclein/chemistry	mitochondrial membranes/metabolism	4.19E-13	8.01E-12	0.033333333	0.684648414	1	0
alpha-synuclein/chemistry	mutant proteins/metabolism	0	0	0.016666667	0.684648414	1	0
alpha-synuclein/chemistry	neurons/pathology	4.19E-13	8.01E-12	0.033333333	0.684648414	1	0
alpha-synuclein/chemistry	organelle size	0	0	0.016666667	0.684648414	1	0
alpha-synuclein/chemistry	parkinson disease/genetics	0.003806631	0.007269691	0.277227723	0.675762622	1	3
alpha-synuclein/genetics	axons/metabolism	0.005795932	0.009193979	0.159235669	0.704306703	1	4
alpha-synuclein/genetics	cations divalent/metabolism	0.003674056	0.007049866	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	cell death/drug effects	0.005795932	0.009193979	0.159235669	0.704306703	1	4
alpha-synuclein/genetics	cell differentiation/genetics	0.00084582	0.001920987	0.040332415	0.155527348	3	3
alpha-synuclein/genetics	cells cultured	0.002989467	0.006007048	0.043910234	0.055923458	4	3
alpha-synuclein/genetics	crispr-cas systems	0.001037649	0.003061288	0.183333333	0.684648414	1	0
alpha-synuclein/genetics	curcumin/pharmacology	9.07E-05	0.000187819	0.082802548	0.704306703	1	4
alpha-synuclein/genetics	dopaminergic neurons/metabolism	5.84E-05	0.000175021	0.009475831	0.004574958	6	3
alpha-synuclein/genetics	dynamins/metabolism	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	endopeptidase clp/antagonists & inhibitors	0.002826062	0.005717711	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	endoplasmic reticulum stress/genetics	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	gain of function mutation	0.002826062	0.005717711	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	gene-environment interaction	0.005795932	0.009193979	0.159235669	0.704306703	1	4
alpha-synuclein/genetics	genes reporter	0.002826062	0.005717711	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	genome human	0.002113975	0.00440206	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	glucosylceramidase/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	homeostasis/physiology	0.003674056	0.007049866	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	induced pluripotent stem cells/metabolism	5.56E-06	1.96E-05	0.004396852	0.001078072	7	3
alpha-synuclein/genetics	induced pluripotent stem cells/pathology	0.002249809	0.003809398	0.159235669	0.704306703	1	4
alpha-synuclein/genetics	lipid metabolism/genetics	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	microtubule-associated proteins/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	microtubules/genetics	0.000140559	0.000374859	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	mitochondria/genetics	0.000121225	0.000329259	0.056730194	0.155527348	3	3
alpha-synuclein/genetics	mutation	0.000165946	0.000440193	0.012361295	0.004574958	6	3
alpha-synuclein/genetics	mutation/drug effects	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	neurons/pathology	0.004922446	0.007906313	0.229751387	0.704306703	1	4
alpha-synuclein/genetics	nf-e2-related factor 2/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	nitric oxide/genetics	0.000140559	0.000374859	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	paraquat/toxicity	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	parkinson disease/drug therapy	0.002319594	0.003926378	0.078740313	0.395836357	2	4
alpha-synuclein/genetics	parkinson disease/genetics	0.001974118	0.004807867	0.000264643	7.22E-06	10	2
alpha-synuclein/genetics	pluripotent stem cells/metabolism	0.002113975	0.00440206	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	protein kinase c/genetics	0.002113975	0.00440206	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	protein transport/genetics	0.000140559	0.000374859	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	reactive nitrogen species/metabolism	6.78E-05	0.000201479	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	recombinant proteins/metabolism	0.002826062	0.005717711	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	substantia nigra/metabolism	0.000406834	0.000964594	0.026876591	0.155527348	3	3
alpha-synuclein/genetics	superoxide dismutase/metabolism	0.002826062	0.005717711	0.108910891	0.675762622	1	3
alpha-synuclein/genetics	tubulin/genetics	0.000140559	0.000374859	0.108910891	0.675762622	1	3
alpha-synuclein/metabolism	antigen presentation	0.001714637	0.004737263	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	astrocytes/immunology	0.001714637	0.004737263	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	brain/drug effects	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	brain/metabolism	1.75E-07	1.10E-06	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	carbonyl cyanide m-chlorophenyl hydrazone/pharmacology	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	cell membrane/metabolism	0.001714637	0.004737263	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	cell respiration	0.000511736	0.0011923	0.097029703	0.675762622	1	3
alpha-synuclein/metabolism	dopamine/metabolism	0.001846066	0.003185439	0.151226762	0.704306703	1	4
alpha-synuclein/metabolism	dopaminergic neurons/cytology	0.004981003	0.007995048	0.179146935	0.704306703	1	4
alpha-synuclein/metabolism	embryonic stem cells/metabolism	6.59E-06	3.33E-05	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	hla-drb1 chains/chemistry	0.001714637	0.004737263	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	induced pluripotent stem cells/cytology	0.004743147	0.008701358	0.140090062	0.360232201	2	3
alpha-synuclein/metabolism	induced pluripotent stem cells/drug effects	0.004060541	0.007696917	0.142634263	0.675762622	1	3
alpha-synuclein/metabolism	inflammation mediators/metabolism	0.001714637	0.004737263	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	lewy bodies/metabolism	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	mesencephalon/cytology	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	mitochondria/metabolism	0.002014976	0.003460298	0.073814755	0.18130336	3	4
alpha-synuclein/metabolism	mitochondrial proton-translocating atpases/metabolism	6.59E-06	3.33E-05	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	mitochondrial turnover/drug effects	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	neurons/metabolism	0.002749007	0.007247383	0.073513708	0.371068466	2	0
alpha-synuclein/metabolism	nf-e2-related factor 2/metabolism	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	organ specificity	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	parkinson disease/metabolism	1.07E-05	3.48E-05	0.02724785	0.155527348	3	3
alpha-synuclein/metabolism	postmortem changes	0.001173863	0.003382612	0.083333333	0.684648414	1	0
alpha-synuclein/metabolism	protein kinases/genetics	0.004905233	0.008945996	0.186377413	0.675762622	1	3
alpha-synuclein/metabolism	stress physiological	0.000270458	0.000664828	0.097029703	0.675762622	1	3
alpha-synuclein/metabolism	tumor necrosis factor-alpha/metabolism	0.001714637	0.004737263	0.083333333	0.684648414	1	0
amides/pharmacology	botulinum toxins/pharmacology	0	0	0.006369427	0.704306703	1	4
amides/pharmacology	caspase 3/metabolism	0.000475505	0.000885677	0.063694268	0.704306703	1	4
amides/pharmacology	myocytes cardiac/drug effects	0	0	0.006369427	0.704306703	1	4
amides/pharmacology	phosphatidylserines/metabolism	7.80E-05	0.000163042	0.050955414	0.704306703	1	4
amides/pharmacology	phospholipid transfer proteins/metabolism	0	0	0.006369427	0.704306703	1	4
amides/pharmacology	pyridines/pharmacology	0	0	0.006369427	0.704306703	1	4
amides/pharmacology	rho gtp-binding proteins/antagonists & inhibitors	0	0	0.012738854	0.704306703	1	4
amides/pharmacology	rho-associated kinases/antagonists & inhibitors	0	0	0.006369427	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	antimycin a/toxicity	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	antineoplastic agents phytogenic/isolation & purification	0.000553775	0.001021783	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	apoptosis/drug effects	0.000160178	0.000320374	1.90E-06	2.39E-06	11	4
amino acid chloromethyl ketones/pharmacology	autophagy/drug effects	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	butylated hydroxytoluene/analogs & derivatives	0.000372622	0.000706423	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	caspase inhibitors	4.71E-12	3.31E-11	0.01980198	0.675762622	1	3
amino acid chloromethyl ketones/pharmacology	cell extracts/pharmacology	0	0	0.00990099	0.675762622	1	3
amino acid chloromethyl ketones/pharmacology	cell hypoxia/drug effects	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	cell nucleus/drug effects	0	0	0.00990099	0.675762622	1	3
amino acid chloromethyl ketones/pharmacology	cell shape/drug effects	2.83E-06	7.21E-06	0.004491262	0.395836357	2	4
amino acid chloromethyl ketones/pharmacology	cell size/drug effects	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	cisplatin/pharmacology	0.000372622	0.000706423	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	cycloheximide/pharmacology	0.000790403	0.001434281	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	cytochrome c group/metabolism	4.54E-08	2.14E-07	0.02970297	0.675762622	1	3
amino acid chloromethyl ketones/pharmacology	deoxyglucose/pharmacology	3.84E-09	1.26E-08	0.000260783	0.18130336	3	4
amino acid chloromethyl ketones/pharmacology	dna fragmentation	1.98E-05	4.46E-05	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	dna fragmentation/drug effects	0.000466417	0.00087366	0.007781347	0.18130336	3	4
amino acid chloromethyl ketones/pharmacology	dose-response relationship drug	1.98E-06	5.11E-06	9.40E-05	0.006469601	6	4
amino acid chloromethyl ketones/pharmacology	esophageal neoplasms/metabolism	0.000553775	0.001021783	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	ethidium/pharmacology	0.000790403	0.001434281	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	hela cells	9.36E-05	0.000193453	0.012952221	0.395836357	2	4
amino acid chloromethyl ketones/pharmacology	hiv protease inhibitors/pharmacology	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	intracellular fluid/drug effects	0.000372622	0.000706423	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	isothiocyanates/pharmacology	0.000790403	0.001434281	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	nitrophenols/pharmacology	1.98E-05	4.46E-05	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	ovarian neoplasms/drug therapy	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	phosphatidylserines/metabolism	0.00124226	0.002200147	0.011960442	0.18130336	3	4
amino acid chloromethyl ketones/pharmacology	plant extracts/isolation & purification	0.000553775	0.001021783	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	saquinavir/antagonists & inhibitors	8.18E-05	0.000170485	0.070063694	0.704306703	1	4
amino acid chloromethyl ketones/pharmacology	stomach neoplasms/metabolism	0.000372622	0.000706423	0.070063694	0.704306703	1	4
amyotrophic lateral sclerosis/genetics	apoptosis/physiology	0.000533403	0.000986779	0.093107427	0.704306703	1	4
amyotrophic lateral sclerosis/genetics	cell death/genetics	1.14E-09	1.02E-08	0.042857143	0.6737233	1	2
amyotrophic lateral sclerosis/genetics	cell differentiation	0.001104319	0.003234644	0.116666667	0.684648414	1	0
amyotrophic lateral sclerosis/genetics	cytoplasm/metabolism	1.14E-09	1.02E-08	0.042857143	0.6737233	1	2
amyotrophic lateral sclerosis/genetics	dna-binding proteins/genetics	0.000196188	0.000604066	0.124862989	0.6737233	1	2
amyotrophic lateral sclerosis/genetics	dna-binding proteins/metabolism	0	0	0.016666667	0.684648414	1	0
amyotrophic lateral sclerosis/genetics	hsp70 heat-shock proteins/metabolism	1.70E-06	6.78E-06	0.04950495	0.675762622	1	3
amyotrophic lateral sclerosis/genetics	locomotion/genetics	1.70E-06	6.78E-06	0.04950495	0.675762622	1	3
amyotrophic lateral sclerosis/genetics	mitochondria/pathology	3.45E-06	1.48E-05	0.08447205	0.6737233	1	2
amyotrophic lateral sclerosis/genetics	mitochondrial proteins/metabolism	0.000384227	0.001258898	0.083333333	0.684648414	1	0
amyotrophic lateral sclerosis/genetics	motor neurons/metabolism	0	0	0.016666667	0.684648414	1	0
amyotrophic lateral sclerosis/genetics	muscles/innervation	1.14E-09	1.02E-08	0.042857143	0.6737233	1	2
amyotrophic lateral sclerosis/genetics	mutation missense	0.000564921	0.001309497	0.018620179	0.360232201	2	3
amyotrophic lateral sclerosis/genetics	mutation missense/genetics	1.70E-06	6.78E-06	0.04950495	0.675762622	1	3
amyotrophic lateral sclerosis/genetics	neuromuscular junction/cytology	1.70E-06	6.78E-06	0.04950495	0.675762622	1	3
amyotrophic lateral sclerosis/genetics	neuromuscular junction/genetics	0.003526076	0.006899146	0.04950495	0.675762622	1	3
amyotrophic lateral sclerosis/genetics	neuromuscular junction/metabolism	0	0	0.001242236	0.357776018	2	2
amyotrophic lateral sclerosis/genetics	phenotype	0.003929835	0.006383575	0.06340957	0.395836357	2	4
amyotrophic lateral sclerosis/genetics	proteasome endopeptidase complex/metabolism	1.70E-06	6.78E-06	0.04950495	0.675762622	1	3
amyotrophic lateral sclerosis/genetics	protein transport	1.14E-09	1.02E-08	0.042857143	0.6737233	1	2
amyotrophic lateral sclerosis/genetics	rna interference	0.002092289	0.003576355	0.093107427	0.704306703	1	4
amyotrophic lateral sclerosis/genetics	synapses/metabolism	4.03E-10	4.86E-09	0.033333333	0.684648414	1	0
amyotrophic lateral sclerosis/genetics	transcription factors/metabolism	0	0	0.016666667	0.684648414	1	0
amyotrophic lateral sclerosis/metabolism	calcium/metabolism	0.001432436	0.003939891	0.064516129	0.682254817	1	1
amyotrophic lateral sclerosis/metabolism	endoplasmic reticulum/metabolism	0.000183612	0.00063942	0.048387097	0.682254817	1	1
amyotrophic lateral sclerosis/metabolism	gene expression	1.20E-06	6.54E-06	0.032258065	0.682254817	1	1
amyotrophic lateral sclerosis/metabolism	glycogen synthase kinase 3 beta/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
amyotrophic lateral sclerosis/metabolism	mitochondrial proteins/metabolism	1.89E-05	5.98E-05	0.069306931	0.675762622	1	3
amyotrophic lateral sclerosis/metabolism	protein tyrosine phosphatases/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
amyotrophic lateral sclerosis/metabolism	rna-binding protein fus/genetics	1.08E-11	1.45E-10	0.016129032	0.682254817	1	1
amyotrophic lateral sclerosis/metabolism	vesicular transport proteins/metabolism	1.05E-05	4.71E-05	0.032258065	0.682254817	1	1
annexin a5/metabolism	benzamides/pharmacology	2.59E-12	1.03E-11	0.025396048	0.704306703	1	4
annexin a5/metabolism	bismuth/pharmacology	0	0	0.00990099	0.675762622	1	3
annexin a5/metabolism	burkitt lymphoma	0	0	0.012738854	0.704306703	1	4
annexin a5/metabolism	calcimycin/pharmacology	0	0	0.012738854	0.704306703	1	4
annexin a5/metabolism	caspase inhibitors	0	0	0.01980198	0.675762622	1	3
annexin a5/metabolism	caspases/drug effects	0	0	0.02970297	0.675762622	1	3
annexin a5/metabolism	cell survival/drug effects	7.67E-05	0.000224774	0.089108911	0.675762622	1	3
annexin a5/metabolism	dna fragmentation/drug effects	0.000392836	0.000740098	0.087457129	0.704306703	1	4
annexin a5/metabolism	dna neoplasm/drug effects	0	0	0.00990099	0.675762622	1	3
annexin a5/metabolism	etoposide/pharmacology	6.43E-06	1.52E-05	0.050465458	0.704306703	1	4
annexin a5/metabolism	hl-60 cells/drug effects	0	0	0.00990099	0.675762622	1	3
annexin a5/metabolism	hydrogen peroxide/pharmacology	1.07E-06	2.83E-06	0.050465458	0.704306703	1	4
annexin a5/metabolism	oligomycins/pharmacology	0	0	0.012738854	0.704306703	1	4
annexin a5/metabolism	organometallic compounds/pharmacology	0	0	0.00990099	0.675762622	1	3
annexin a5/metabolism	oxidative stress	0.000184633	0.000367333	0.099624367	0.704306703	1	4
annexin a5/metabolism	quinazolinones	0	0	0.012738854	0.704306703	1	4
annexin a5/metabolism	tumor cells cultured	0.000329725	0.000627915	0.075208231	0.704306703	1	4
anti-inflammatory agents/pharmacology	antioxidants/pharmacology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	cachexia/etiology	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	caspases/metabolism	0.001820581	0.003843069	0.03960396	0.675762622	1	3
anti-inflammatory agents/pharmacology	cell death	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	cell survival	4.52E-06	1.60E-05	0.01980198	0.675762622	1	3
anti-inflammatory agents/pharmacology	cytokines/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	inflammation/drug therapy	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	leukocytes mononuclear/drug effects	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	neoplasms/complications	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	oxidants/metabolism	7.46E-09	3.79E-08	0.00990099	0.675762622	1	3
anti-inflammatory agents/pharmacology	oxidative stress/drug effects	0.003172487	0.006322346	0.059405941	0.675762622	1	3